Scientific Program

The Scientific Program is subject to minor changes.

Wednesday 04 March

ISGE 1 Opening Ceremony 10:00-10:30
ADD FAVOURITE

Welcome in Rome

ISGE 2 Symposium 10:40-12:10
ADD FAVOURITE

Modern menopause management: from latest evidence on transdermal hormonal treatment to meaningful conversations in women’s health

Sponsored by Gedeon Richter
chairpersons: Claudio Soares , Rossella Nappi
  • Joyce Harper (GB)
    Navigating menopause: empowering women in life and work
  • Angelica Lindén Hirschberg (SE)
    Transdermal MHT in focus: estradiol spray’s precision pathway to personalized symptom relief
  • Rossella Nappi (IT)
    Menopause matters: ending the hormone holdback
ISGE 3 Symposium 10:40-12:10
ADD FAVOURITE

Adolescent gynecological endocrinology

chairpersons: Anna Maria Fulghesu , Sarah Berga
  • Zoran Stankovic (RS)
    Challenges in modern pediatric and adolescent gynecology
  • Charles Sultan (FR)
    Adult consequences of female precocious puberty
  • Žana Bumbulienė (LT)
    Navigating the Maze of Adolescent Uterine Bleeding
  • Efthimios Deligeoroglou (GR)
    PCOS in lean adolescents
ISGE 4 Symposium 10:40-12:10
ADD FAVOURITE

Understanding and managing infertility

chairpersons: Luigi Nappi , Inmaculada Moreno
  • Eileen Manalo (PH)
    Managing fertility in the late reproductive years
  • Basil Tarlatzis (GR)
    Ovarian stimulation: does the type of gonadotropin matter?
  • Antonio Pellicer (IT)
    How IVF affects the risks of pregnancy
  • Luca Gianaroli (IT)
    Oocyte donation: is it the solution?
ISGE 5 Symposium 10:40-12:10
ADD FAVOURITE

The gynecologic impact of uterine disorders

chairpersons: Ludovico Muzii , Nicola Pluchino
  • Steven Goldstein (US)
    Understanding endometrial function and dysfunction: the role of ultrasounds
  • Leila Adamyan (RU)
    Complex uterine surgery
  • Camil Castelo-Branco (ES)
    Can we create custom/tailored neovaginas in (Rokitanskys-Morrisa)?
  • Stefano Luisi (IT)
    Modern medical management of myomas
ISGE 6 Scientific Society Symposium 10:40-12:10
ADD FAVOURITE

Obesity: A Gender-Sensitive Challenge in Women’s Health

Organized by Asociación Argentina para el Estudio del Climaterio (AAPEC)
chairperson: María Franchina
  • Rita Caro (AR)
    Obesity and Cardiovascular Disease: How can we prevent gender inequity and reduce risk?
  • Claudia Rey (AR)
    Obesity and Oncologic Risk: An Issue Not Frequently Addressed
  • Analía Pesado (AR)
    Obesity and its Impact on Non-Communicable Diseases: Can We Decrease the Risk?
  • Gustavo Litterio (AR)
    Current Treatment and New Perspectives: Is Pharmacology the Definitive Solution?
ISGE 7 Oral Presentation 10:40-12:10
ADD FAVOURITE

Cervical and endometrial cancer

chairpersons: Enrico Vizza , Alla Vash-Margita
  • Tetiana Adam (UA)
    Pathomorphological markers of oncogenesis in atypical endometrial hyperplasia
  • Nino Museridze (GE)
    Prevention of HPV recurrence with HPV vaccination after laser vaporization and conization in reproductive-age patients with hsil-cin 2
  • Madona Jugeli (GE)
    High‑grade cervical and anal intraepithelial neoplasia in reproductive-age women with high-risk hpv: a prospective study using high‑resolution anoscopy
  • Teona Turashvili (GE)
    Molecular Markers of Endometrial Ciliary Metaplasia and Their Role in Endometrial Carcinogenesis
  • Florin Isopescu (RO)
    Clinical factors influencing outcomes colpo-cyto-histological discrepancies in the diagnosis of cervical lesions
  • Oleh Revenko (UA)
    The impact of war factors on reproductive dysfunction in women with uterine neoplasms in Ukraine
  • Sara Oliveira (PT)
    HPV and contraception: what are the differences between contraceptive methods?
  • Julia Stevenson (US)
    Prevalences of HPV Vaccination and Cervical Dysplasia Among Patients with Müllerian Anomalies at a Tertiary Healthcare Center
  • Iryna Netskar (UA)
    Endometrial hyperplasia, atypical hyperplasia – in the prime of reproductive age in Ukrainian women during the war.
  • Yilin Yang (CN)
    Prevalence and Genotype Distribution of High-Risk Human Papillomavirus Infection among Chinese Women Aged 35-64:A National Cross-Sectional Study
  • Marija Gjorgoska (SI)
    Comparative Transcriptomic Profiling of MMR-Deficient and MMR-Proficient Advanced Endometrial Cancers Identifies Therapeutic Vulnerabilities in MMR-Proficient Tumors
ISGE 8 Oral Presentation 10:40-12:10
ADD FAVOURITE

PCOS 1

chairpersons: Rosanna Apa , Lara Tiranini
  • Lara Tiranini (IT)
    Ontogenesis of polycystic ovary syndrome (PCOS): both parents seem to count in our clinical experience.
  • Neha Gangane (IN)
    Study of inflammatory factors- neutrophil to lymphocyte ratio (NLR) and platelet to lymphocyte ratio (PLR) in lean vs obese PCOS adolescent patients: a case control study
  • Ofeliia Bettikher (RU)
    PCOS features: the role of ethnicity
  • Nina Tirso (BA)
    Melatonin Enhances Metformin’s Benefits on Lipid Metabolism and reduces Obesity markers in a Rat Model of Testosterone-Induced Polycystic Ovary Syndrome
  • Mihaela Krasteva (BG)
    Abnormal Uterine Bleeding in Perimenopause: Underlying Pathologies, Diagnostic Challenges, Clinical Burden of Anemia, and Emerging Therapeutic Perspectives
  • Anastasia Trouva (SE)
    Maternal thyroid function as a predictor of markers of insulin resistance in pregnant women with polycystic ovary syndrome
  • Ritu Kushwah (IN)
    Arterial stiffness and Vascular dysfunction in Lean versus Overweight women with Polycystic ovary syndrome (PCOS) - A Cross-Sectional Study
  • Swati Tomar (IN)
    Anti-mullerian hormone as a surrogate marker of insulin resistance assessment in lean versus overweight/obese women with polycystic ovarian syndrome
  • Vera Andreeva (RU)
    The role of advanced glycation end products and glypican-4 in the pathogenesis of polycystic ovary syndrome in adolescents
  • Charmila Ayyavoo (IN)
    Is there a relationship between age at menarche and the development of PCOS?
  • Aleksandre Asanidze (GE)
    Recurrent Pregnancy Loss in PCOS: The Role of Hyperhomocysteinemia and Insulin Resistance
ISGE 9 Scientific Society Symposium 10:40-12:10
ADD FAVOURITE

Le novità in tema di trattamento in GinecologiaEndocrinologica

Organized by Associazione Italiana di Ginecologia Endocrinologica (AIGE)
chairpersons: Andrea Giannini  , Massimo Stomati
  • Stefano Luisi (IT)
    Endometriosi, fibromatosi e menometrorragie: il ruolo degli antagonisti del GnRH
  • Alessandro D Genazzani (IT)
    Il trattamento con estradiolo a bassa dose nella amenorrea ipotalamica funzionale (FHA)
  • Christian Battipaglia (IT)
    Insulino resistenza e transizione menopausale: il ruolo della integrazione specifica
ISGE 10 Scientific Society Symposium 10:40-12:10
ADD FAVOURITE

Endometriosis throughout life, beyond the reproductive stage

Organized by Asociación Latinoamericana de Endocrinología Ginecológica (ALEG)
chairpersons: Susana Pilnik , Selva Lima
  • Poli Mara Spritzer (BR)
    Endometrosis and Cardiovascular Risk; Evidence and Clinical Gaps
  • Alejandro Manzur Yanine (CL)
    Hormonal Replacement in patients with endometriosis history
  • Alejandra Belardo (AR)
    Beyond Fertility: Endometriosis in the Peri and Postmenopausal Period
  • Margot Acuña San Martin (CL)
    Discussion
  • Alejandro Rosas Balan (MX)
    Discussion
ISGE 1 Lunch Symposium 12:30-14:00
ADD FAVOURITE

Advancing pregnancy care: new clinical data on pregnancy complications and preventive strategies

Sponsored by Besins Healthcare
chairpersons: Andrea Genazzani , Peter Chedraui
  • Henriette Svarre Nielsen (DK)
    The Copenhagen pregnancy loss study: understanding pregnancy loss to improve care
  • Giancarlo Di Renzo (IT)
    Great Obstetrical Syndromes: new insights into progesterone's role and clinical implications
  • Zulfiya Khodzhaeva (RU)
    The NEWLIFE data: optimizing intravaginal progesterone use to prevent miscarriage in high-risk women
ISGE 1 Therapeutic Forum 14:15-15:15
ADD FAVOURITE

Medical strategies to manage stress-related cycle disorders

chairperson: Annibale Volpe
  • Blazej Meczekalski (PL)
    Medical strategies to manage stress-related cycle disorders
ISGE 2 Meet the Expert 14:15-15:15
ADD FAVOURITE

Family planning in a changing World

chairpersons: Andrzej Milewicz , Antonio Pellicer
  • Xiangyan Ruan (CN)
    Hormonal contraception: Asian vs. Western World
  • Martin Birkhaeuser (CH)
    Hormonal contraception in an ageing World
ISGE 3 Symposium 14:15-15:15
ADD FAVOURITE

HCC: a new frontier in vulvo-vaginal health

Sponsored by IBSA Institut Biochimique
chairpersons: Rossella Nappi , Nilson Roberto De Melo
  • Nilson Roberto De Melo (IT)
    Welcome and introduction
  • Joaquin Calaf Alsina (ES)
    Setting the scene : unmet needs in GSM & VVA
  • Sophie Menkes (CH)
    HCC in Vulvovaginal Health: from theory to practice
  • Francesco Meani (CH)
    Identifying patient profile: who benefits most from HCC?
  • Rossella Nappi (IT)
    Integrating HCC into clinical protocols - Closing remarks
ISGE 4 Symposium 14:15-15:15
ADD FAVOURITE

Redefining women’s health from adolescence to lifelong strength

Organized by EGOI-PCOS
chairpersons: Fabio Facchinetti  , Lali Pkhaladze
  • Simone Garzon (IT)
    Adolescence unplugged - Decoding menstrual disorders and emerging therapies
  • Svetlana Spremović Radjenović (RS)
    Through the lens: PCOS, phenotype D and new horizons in treatment
  • Roberto Baldelli (IT)
    D-chiro-inositol: shaping the future of bone health
ISGE 5 ISGE Scholarship course 14:15-17:15
ADD FAVOURITE

Course 1

  • Frederick Naftolin (US)
    The biological basis of ovulation
  • Sarah Berga (US)
    The neuroendocrine mysteries of hypothalamic amenorrhea
  • Angelica Linden Hirshberg (SE)
    Why muscle and fat are important for the menstrual cycle
ISGE 6 Oral Presentation 14:15-15:15
ADD FAVOURITE

Long-Acting Reversible Contraception (LARC)

chairpersons: Costantino Di Carlo , Michelle Paola Carrera Hernández
  • Edson Santos Ferreira-Filho (BR)
    Bleeding pattern, satisfaction and continuity rates, and quality of life in women with breast cancer using the copper and silver IUD or the copper IUD: a randomized clinical trial
  • Edson Santos Ferreira-Filho (BR)
    Satisfaction rate among women with congenital heart disease using a 68 mg etonogestrel-releasing subdermal implant: a cross-sectional study
  • Natalia Queiroz de Santana (BR)
    Continuation rate and determinants of contraceptive method use In women in Bahia
  • Michelle Paola Carrera Hernández (MX)
    Prevalence of long-term contraception in induced abortion in private msi mexico clinics
  • Vidushi Kulshrestha (IN)
    Single centre experience of Implanon-Nxt, the newly introduced single rod subdermal contraceptive implant in India
  • Natalie Gadelha Oliveira (BR)
    Satisfaction and continuation rates with LARCs in a Public Family Planning Service in Brazil
  • Alexandra Axenova (RU)
    Contraceptive and Fertility-Preservation Strategies for Female Astronauts: Lessons from Isolated and Analog Environments for Long-Duration Space Missions
ISGE 7 Oral Presentation 14:15-15:15
ADD FAVOURITE

Pregnancy

chairpersons: Lorenza Driul , Aleksandre Asanidze
  • Mushtariybonu Mamasoliyeva (UZ)
    Рrеgnаnсy аnd lаbоr mаnаgеmеnt tасtiсs in wоmеn оf lаtе rерrоduсtivе реriоd: а рrоsресtivе studу оf сliniсаl оutсоmеs
  • Valerija Raksa (LV)
    Newborn Feeding and Maternal Support: Trends in Communication, Emotional Health and Care (2020–2023)
  • Arised Guadalupe Juárez-Reyes (MX)
    Mixed Th1/Th2 and innate/adaptive immune responses at the late 2nd trimester associate with preterm birth.
  • Vazira Abdusamatova (UZ)
    Endocrine Disorders in Pregnancy: Innovative Approaches to Diagnosis and Management
  • Alberto N. Peón (MX)
    Cervico-vaginal immunosecretomes, rather tan comunity state-type-IV are associated with preterm labor
ISGE 8 Scientific Society Symposium 14:15-15:15
ADD FAVOURITE

Deficiencia de Vitamina D y su impacto en la salud reproductiva de la mujer mexicana.

Organized by Asociación Mexicana De Endocrinología Ginecológica (AMEGIN)
  • Eduardo Guzmán González (MX)
    Conclusiones de la Guía de la Endocrine Society sobre el uso de Vitamina D
  • Alejandro Rosas Balan (MX)
    Prevalencia de deficiencia de Vitamina D en embarazadas adolescentes
  • Enrique Reyes Muñoz (MX)
    Riesgo de Diabetes Mellitus Gestacional en mujeres mexicanas con deficiencia de Vitamina D medida en el primer trimestre del embarazo
ISGE 9 Scientific Society Symposium 14:15-15:15
ADD FAVOURITE

Recent Diagnostic Approaches, Tools and Treatment Options for Women with Endometriosis from a Latvian Perspective

Organized by Latvian Society of Gynecological Endocrinology
chairperson: Dace Matule
  • Vija Veisa (LV)
    Key Aspects in the Diagnosis of Endometriosis
  • Dace Matule (LV)
    GnRH Antagonist Combination Therapy in the Treatment of Endometriosis
  • Lāsma Līdaka (LV)
    Combined Oral Contraception in the Treatment of Endometriosis, the Latest Findings
ISGE 10 Scientific Society Symposium 14:15-15:15
ADD FAVOURITE

Symposium

Organized by Gynecological Endocrine Society of India (GESI)
chairpersons: Vidushi Kulshrestha , Amol Lunkad
  • Rajesh Khadgawat (IN)
    Transgender Clinic: experience from India
  • Nutan Agarwal (IN)
    Metformin vs Myoinositol for menstrual regulation in PCOS
  • Garima Kacchawa (IN)
    Dopamine Agonists in Endometriosis: The New Kid on the Corner
ISGE 1 Symposium 15:45-17:15
ADD FAVOURITE

Across indications: from clinical evidence to daily practice in endometriosis & uterine fibroids management

Sponsored by Gedeon Richter
chairpersons: Matts Olovsson , Ludwig Kiesel
  • Silvia Vannuccini (IT)
    Relugolix combination therapy: one pill for two indications
  • Attilio Di Spiezio Sardo (IT)
    Applying clinical evidence in endometriosis: case-based insights
  • Josep Estadella Tarriel (ES)
    Applying clinical evidence in uterine fibroids and comorbidities: case-based insights
ISGE 2 Symposium 15:45-17:15
ADD FAVOURITE

Highlights on osteoporosis

chairpersons: Alfredo Pontecorvi , Antonio Lanzone
  • Antonio Cano (ES)
    Bone anabolic drugs, the other pathway in bone metabolism
  • Florence Tremollieres (FR)
    MHT and the bone
  • Santiago Palacios (ES)
    Are SERMs outdated?
  • Mark Brincat (MT)
    The intervertebral disk: the silent problem
ISGE 3 Symposium 15:45-17:15
ADD FAVOURITE

Breaking the silence: insomnia disorder during menopausal transition

Sponsored by Idorsia
chairpersons: Tommaso Simoncini , Zoe Schaedel
  • Tommaso Simoncini (IT)
    Setting the stage: understanding insomnia disorder during menopause transition
  • Petra Stute (CH)
    The hidden burden: unmasking the impact of insomnia disorder during menopausal transition
  • Rosalia Silvestri (IT)
    Bridging the gap: navigating treatment challenges and patient needs during menopausal transition
  • Zoe Schaedel (GB)
    Targeted solutions: daridorexant insights in insomnia disorder during menopausal transition
  • ()
    Q&A
ISGE 4 Symposium 15:45-17:15
ADD FAVOURITE

Obstetric Endocrinology

chairpersons: Irene Cetin , Giuseppe Rizzo
  • Howard J. A. Carp (IL)
    Recurrent Miscarriage - The resistant patient
  • Gian Carlo Di Renzo (IT)
    Current gaps in prevention and predition of preterm birth
  • Herbert Valensise (IT)
    Current concepts on fetal growth restriction
  • Shantha Kumari (IN)
    Obstetric Endocrinology or Current concepts in Pre Eclampsia
ISGE 6 Oral Presentation 15:45-17:15
ADD FAVOURITE

Fertility preservation

chairpersons: Stefano Angioni , Anna Cicigoi
  • Giulia Garbin (IT)
    Predicting ovarian response in women undergoing fertility preservation: AFC vs AMH
  • Ayse Nur Cakir Gungor (TR)
    Can omegaven avoid the destructive effect of procarbazine over ovarian reserve?
  • Anming Liu (CN)
    Hormonal analysis after xenotransplantation of human ovarian tissue after cryopreservation using classical DMSO vs. new L-proline
  • Elisa Casula (IT)
    Clinical Efficacy and Cost-Effectiveness of Progestin-Primed Ovarian Stimulation (PPOS) versus GnRH Antagonist Protocols: A Retrospective Study from a Single Assisted Reproduction Center
  • Kaiyin Li (CN)
    Premature puberty induced by hematopoietic stem cell transplantation: a case report
  • Ying Zhang (CN)
    Time-Series Transcriptomic Profile in the Early Stage of Rat Fresh Ovary Auto-transplantation
  • Ludmila Barbakadze (GE)
    Different Timing, Same Results: Ovulation Induction Strategies in Fertility Preservation
  • Mayara Alves (BR)
    Frozen-Thawed Ovarian Autografts Treated with Scaffold-Based Melatonin Delivery in Rats
ISGE 7 Oral Presentation 15:45-17:15
ADD FAVOURITE

Metabolic syndrome and obesity

chairpersons: Ineta Vasaraudze , Zecheng Wang
  • Federica Barbagallo (IT)
    Association Between Follicle-Stimulating Hormone Levels and Metabolic Health in Postmenopause
  • Cher Dallal (US)
    Indirect and Direct Measures of Adiposity: A Metabolomic Profiling Pilot Study among African-American and White Breast Cancer Survivors
  • Ifigeneia Avgousti (GR)
    Anthropometric and Hormonal Predictors Across the Liver Disease Spectrum
  • Zecheng Wang (CN)
    Metabolic Syndrome in Adolescent Girls with Premature Ovarian Insufficiency Following Hematopoietic Stem Cell Transplantation
  • Aneta Sima (MK)
    Carotid Intima-Media Thickness (CIMT) in Association with Metabolic Syndrome in Perimenopause
  • Nataliia Mokrianyn (UA)
    The Impact of Obesity on Endometrial Hyperplasia in Wartime Conditions in Ukraine
  • Negina Adkhamova (UZ)
    The Role of Genetic Testing in Endocrinology: Three Exome Sequencing-Based Clinical Cases of Overweight Women
  • Abdurakhmon Bakhromov (UZ)
    Functional characteristics of the thyroid gland in metabolic syndrome
  • Marina Martinelli Sonnenfeld (BR)
    Beyond Symptom Relief: The Role of Hormone Therapy in Shaping Body Composition After Menopause
ISGE 8 Scientific Society Symposium 15:45-17:15
ADD FAVOURITE

Future Perspectives in Gynecologic Oncology

Organized by Societe europeenne de la langue francaise et allemande de gynecologie and d’obsterique (SELFAGO)
chairpersons: René Druckmann , Christian Singer , Walther Kuhn
  • Christian F. Singer (AT)
    The improved long-term outcome in denosumab-treated breast cancer patients is driven by progesterone receptor status
  • Laura Sabiani (FR)
    Managing premature menopause after gynecologic cancer: balancing hormonal safety and quality of life
  • Christian Kuhn (DE)
    Adjuvant chemotherapy and its impact on overall survival in endometrial carcinoma: a retrospective cohort study of 5,000 patients from Bavaria, Germany (2017-2023)
  • Claus M. Schlotter (DE)
    Impact of proliferation marker Ki67% and genomic signatures in early hormone receptor positive/ HER2 negative (HR+/HER2-) breast cancers: definition of subtypes and therapy decision making
  • Walther Kuhn (DE)
    Paradigm shift in the management of advanced ovarian cancer, the impact of neoadjuvant treatment
ISGE 9 Scientific Society Symposium 15:45-17:15
ADD FAVOURITE

Perspectivas actuales en el manejo de mujer climaterica

Organized by FLASCYM
chairpersons: Maria Soledad Vallejo , Alejandro Caba Paradas
  • Luis Hernández Guzmán (GT)
    Como Elegir el mejor progestágeno en THM
  • Jorge Vargas Guzman (DO)
    Selección de la ruta de administración de la THM
  • Cuauhtémoc Celis González (MX)
    Sarcopenia en la mujer: oportunidades terapéuticas
ISGE 10 Scientific Society Symposium 15:45-17:15
ADD FAVOURITE

PCOS in Focus: Integrating Neuroendocrine, Metabolic, and Reproductive Dimensions with Regional Insights from the Caucasus

Organized by The Georgian Reproductive Endocrinology Association (GREA)
  • George Tevdorashvili (GE)
    The Hormonal Triangle of Polycystic Ovary Syndrome: From Endocrine Crosstalk to Clinical Outcomes
  • Mariami Andguladze (GE)
    Neuroendocrine Foundations of PCOS: GABAergic Dysregulation and Beyond
  • Madona Jugeli (GE)
    Diversity and Distinct Features of the Reproductive Tract Microbiome in Women with PCOS
  • Bella Jugeli (GE)
    Metabolic Signatures of PCOS: Clinical and Translational Perspectives
  • Ana Ardashelia (GE)
    Adolescent PCOS: Early Endocrine Signals and Long-Term Reproductive Health
ISGE 1 Key Lecture 17:20-18:10
ADD FAVOURITE

Presidential Lecture: 40 years of gynecological endocrinology: from the past to the future

  • Andrea Riccardo Genazzani (IT)
    40 years of gynecological endocrinology: from the past to the future
ISGE 1 Key Lecture 18:10-18:40
ADD FAVOURITE

Fred Naftolin Lecture: Treatment of osteoporosis in 2026: a sartorial approach

chairperson: Frederick Naftolin
  • Jean-Yves Reginster (CH)
    Treatment of osteoporosis in 2026: a sartorial approach.
ISGE 1 Key Lecture 18:45-19:15
ADD FAVOURITE

Bruno Lunenfeld Lecture: Understanding sex Hormones and breast cancer

chairperson: Alfred Mueck
  • Richard Santen (US)
    Understanding sex Hormones and breast cancer
ISGE 1 Poster Session 19:15-20:30
ADD FAVOURITE

Posters

  • Tomomi Seki (JP)
    P.001 Influence of anti-Müllerian hormone self-testing on reproductive awareness and lifestyle behaviors in employed women
  • Tamara Dojcinovic (BA)
    P.002 Therapeutic considerations in delayed puberty due to idiopathic hypogonadotropic hypogonadism
  • Kheda Erzanukaeva (RU)
    P.003 Absence of pregravid preparation in a patient with type 1 diabetes mellitus: a clinical case
  • Dildora Eshonkhodjaeva (UZ)
    P.004 Analysis of the causes and treatment tactics of secondary hypomenstrual syndrome in young women
  • Dildora Eshonkhodjaeva (UZ)
    P.005 Stress as a risk factor for secondary hypomenstrual syndrome in young women
  • Tea Khurodze (GE)
    P.006 Rare case of Isolated Hypogonadotropic hypogonadism with concomitant osteoporosis
  • Dilafruz Maksudova (UZ)
    P.007 Non-Hormonal Biomarkers of Metabolically Associated Infertility in Overweight and Obese Women
  • Jelena Malinovic Pancic (BA)
    P.008 Rare Coexistence of Ovarian Teratoma and Adrenal Ganglioneuroma in a Young Woman: From Endocrine Tumors to Successful Pregnancy
  • Tomomi Seki (JP)
    P.009 Generation of Functional Kisspeptin Neurons from Human Embryonic Stem Cells
  • Svetlana Smirnova (RU)
    P.010 Type 1 diabetes and pregnancy: assessment of glycemic control at the stage of pregravid preparation and in the first trimester
  • Nodira Sulaymanavo (UZ)
    P.011 Vaccine prevention of papillomavirus (hpv) infection in uzbekistan: results and prospects
  • Sevinj Yahyayeva (AZ)
    P.012 The Role of Anti-Müllerian Hormone in Reproductive Health Pathology in Female Military Personnel
  • Ekaterina Antonova (RU)
    P.013 A clinical case of a patient with Cushing's syndrome, who was initially treated and monitored for a long time with a diagnosis of PCOS (Polycystic Ovary Syndrome)
  • Larissa Bueno (BR)
    P.014 Impact of Androgen Exposure on Heart Rate Variability in Women with PCOS and Transgender Men under Gender-Affirming Hormone Therapy
  • Victoria Bugai (MD)
    P.015 Hirsutism and Body Image Dissatisfaction among Women with PCOS: A Cross-Sectional Study
  • Maria Carolina Caporale Madi (BR)
    P.016 Critical Insights from a Case Report of Premature Ovarian Insufficiency (POI) and Nonclassic Congenital Adrenal Hyperplasia (NCAH): The Importance of Accurate Diagnosis for Pregnancy and Genetic Counseling
  • Svetlana Dubrovina (RU)
    P.017 The personalized approach for MHT selection according to women androgen status during menopausal transition
  • Fatima Ester Gaitan Vallecillo (NI)
    P.018 Amenorrhea and Hyperandrogenism: The Hidden Sign of Corticoadrenal Carcinoma
  • Andra Kerševičiūtė (LT)
    P.019 Hyperandrogenism in a postmenopausal woman caused by a rare ovarian Leydig cell tumor: a case report
  • Hidayat Mammadzada, MD (AZ)
    P.020 A male patient who learned he was female at the age of 48 - an interesting case of CAH
  • Tiberiu Gabriel Manole (RO)
    P.021 Complete Androgen Insensitivity Syndrome - Diagnostic Challenges and Therapeutic Considerations
  • Anna Markosyan (AM)
    P.022 A Case of Complete Androgen Insensitivity Syndrome: From Genetic Diagnosis to Post-Orchiectomy Hormonal Therapy
  • Victoria Monterrey Perera (ES)
    P.023 Virilization in a Reproductive-Aged Woman Caused by an Ovarian Sertoli-Leydig Cell Tumor: A Case Report
  • Natalija Pavlovic (RS)
    P.024 Changes in blood pressure value in transmales before and during testosterone therapy
  • Rafael Rios (CL)
    P.025 Evaluation of empathic capacity in a chilean population with male gender incongruence and male and female controls through the application of the cadbrigde test, effect of testosterone theraphy
  • Dzhilietta Avetisian (RU)
    P.026 The role of DNA methylation, histone modifications, and non-coding RNA expression in the pathogenesis of premature ovarian insufficiency and innovative ways to overcome infertility from the point of epigenetic disturbances
  • Christian Battipaglia (IT)
    P.027 Effects of oral low-dose estradiol supplementation on the reproductive axis and neuroendocrine profile in patients with functional hypothalamic amenorrhea
  • Taisa Bojovic (RS)
    P.028 “Triple-Double”- Complete Androgen Insensitivity Syndrome in Three Sisters
  • Adishah Çerma (AL)
    P.029 Isolated Hypogonadotropic Hypogonadism in a 17-years old female patient with primary amenorrhea
  • Nadia Díaz Nakamura (ES)
    P.030 Premature Ovarian Insufficiency (POI) secondary to radiotherapy and chemotherapy diagnosed due to primary amenorrhea.
  • Tania Errasti (ES)
    P.031 Energy availability as a key modulator of ovulatory function in lean PCOS
  • Fatima Ester Gaitan Vallecillo (NI)
    P.032 Mayer-Rokitansky-Küster-Hauser Syndrome
  • Patricia Jorge Schwenck de Carvalho (BR)
    P.033 AmenoApp: a digital tool for the differential diagnosis of amenorrhea
  • Krittanai Kuntheekan (TH)
    P.034 Diagnosis of abnormalities on pituitary MRI in women with hypogonadotropic hypogonadism at gynecological clinic in a quaternary hospital
  • Anna Luiza Maffessoni (BR)
    P.035 Beyond Premature Ovarian Insufficiency: The Differential Sexual Impact of Primary and Secondary Amenorrhea
  • Ramunė Narutytė (LT)
    P.036 Swyer Syndrome (46,XY Complete Gonadal Dysgenesis): A Case Report and Review of Multidisciplinary Management
  • Ana Júlia Rizzanti (BR)
    P.037 Clinical Heterogeneity of Premature Ovarian Insufficiency: Impact of Etiology and Amenorrhea Status.
  • Shovkat Sadigova (AZ)
    P.038 Primary and secondary amenorrhea
  • Nicole Tegg (CA)
    P.039 Impact of Functional Hypothalamic Amenorrhea on Cardiovascular Disease Risk in Physically Active Women: A Systematic Review and Meta-Analysis
  • Polina Tsabai (RU)
    P.040 Uterovaginal anomalies and diminished ovarian reserve in a patient with MYRF-associated disease
  • Chandrika Anand (IN)
    P.041 Phthalate Exposure in PCOS: Evidence from a Clinic-Based Case–Control Study in Bangalore
  • Chandrika Anand (IN)
    P.042 PCOS Phenotypes in a South Indian Referral Cohort: Mapping Distribution and Clinical–Biochemical Differentiation
  • Elena Andreeva (RU)
    P.42b Steroid profile characteristics in patients with polycystic ovary syndrome
  • Isela Elizabeth Bañuelos Martinez (ES)
    P.043 Effect of oral Drospirenone on clinical and/or biochemical hyperandrogenism in polycystic ovarian syndrome: A pilot study
  • Luiza Bortoloti Dias (BR)
    P.044 Evaluation of the metabolic and androgenic profile in women with polycystic ovary syndrome
  • Pablo Carpintero (AR)
    P.045 From Reproductive to Cardiometabolic Health: Postmenopausal Risk in Women With Prior PCOS
  • Mingyue Chang (CN)
    P.046 Modified Banxia Xiexin Decoction Ameliorates Polycystic Ovary Syndrome in a Dehydroepiandrosterone-Induced Rat Model
  • Prodipta Chowdhury (BD)
    P.047 Bone mineral density in women with polycystic ovary syndrome
  • Alexandra Cristofor (RO)
    P.048 Genetic and Epigenetic Testing in Gynecologic Endocrinology: From Theory to Clinical Relevance
  • Meri Davitadze (GB)
    P.049 Socioeconomic and linguistic determinants of patient preferences for educational formats and media in polycystic ovary syndrome: a multicentre mixed-methods study
  • Amogh Ananda Rao (US)
    P.040b A Machine-Learning–Based Approach to Mapping Lifestyle Archetypes to Determine Suicidality Risk in PCOS
  • Andreia Fernandes (ES)
    P.050 Clinical benefits of a patented food supplement with 3.6:1 (1100mg:300mg) myo-inositol/d-chiro-inositol, antioxidants and essential vitamins in PCOS treatment: evidence from a spanish cohort
  • Ani Gorgadze (GE)
    P.051 The Link Between Polycystic Ovary Syndrome (PCOS) and Oral Health: Exploring Inflammatory and Hormonal Interactions
  • Elena Grodnitskaya (RU)
    P.052 Eating disoders in women with polycystic ovary syndrome
  • Plamena Kabakchieva (BG)
    P.053 Quality of Life and Sexual Function Across PCOS Phenotypes: A Cross-sectional Case–Control Study
  • Plamena Kabakchieva (BG)
    P.054 Beyond BMI: An Integrated Biomarker Signature of Metabolic Risk in PCOS
  • Satit Klangsin (TH)
    P.055 A Randomized Crossover Trial of Estetrol Versus Ethinyl Estradiol in Polycystic Ovary Syndrome: Effects on Hormonal and Clinical outcomes
  • Catalina Linga (MD)
    P.056 Expulsion of a large polypoid endometrial mass in a young woman with polycystic ovary syndrome following sequential hormonal therapy: a case report
  • Catalina Linga (MD)
    P.057 Severe hyperandrogenism in an adolescent with polycystic ovary syndrome and suspected late-onset adrenal hyperplasia – case report
  • Hidayat Mammadzada, MD (AZ)
    P.058 Ischemic stroke history developed in a 39-year-old female patient due to long-term OCS use combined with risk factors
  • Natsuki Miyake (JP)
    P.059 Association of Serum Anti-Müllerian Hormone with Menstrual Irregularities and Polycystic Ovary Syndrome in a General Cohort of Young Women in Japan
  • Kseniia Ostrovska (UA)
    P.060 Excess Lactose and Insulin Resistance in Young Women with Polycystic Ovary Syndrome
  • Elisabed Pkhaladze (GE)
    P.061 The Role of Age and Weight in Shaping Metabolic Profiles in Classic PCOS
  • Ioana Maria Posea (RO)
    P.062 Not All About Periods: Prolactin’s Variation in Women with PCOS Treated with Metformin.
  • Xusa Sanz-Llorens (ES)
    P.063 Effects of a Nutritional Supplement Based on Inositols, Zinc, Curcumin, and Vitamin D on Bioelectrical and Metabolic Parameters in Women with Polycystic Ovary Syndrome
  • Nicole Schumacher (BR)
    P.064 Indole-3-propionic acid, glycemic index, and insulin resistance in women with and without polycystic ovary syndrome
  • Veronica Setti (IT)
    P.065 Combined treatment with L-Glutathione, D-Chiro-Inositol, Myo-inositol and N-Acetylcysteine reduces insulin resistance in overweight/obese patients with polycystic ovary syndrome (PCOS).
  • Alanis Yael Szyferman (AR)
    P.066 Adiponectin levels in women with polycystic ovary syndrome treated with thiazolidinediones: a systematic review and meta-analysis of randomized controlled trials
  • Iroda Tojieva (UZ)
    P.067 Clinical and Metabolic Predictors of Polycystic Ovary Syndrome: Insights from Phenotype Analysis
  • Iroda Tojieva (UZ)
    P.068 Polycystic Ovary Syndrome in the Light of the New FIGO 2022 Classification: Endocrine and Metabolic Perspectives
  • Raynara Uchôa Gomes (BR)
    P.069 Pathophysiological, Diagnostic, and Phenotypic Perspectives in PCOS: A Narrative Review
  • Vitali Vashakidze (GE)
    P.070 Possible links and challenges in PCOS and T1DM coexistence
  • Voloceai Victoria (MD)
    P.071 Perinatal outcomes in women with polycystic ovary syndrome
  • Zarina Xatamova (UZ)
    P.072 Thyroid Dysfunction and Hormonal Imbalance in Women with Polycystic Ovary Syndrome.
  • Vesselina Yanachkova (BG)
    P.073 Comparative effects of Inositol-based therapy, Metformin, Berberine, and their combination on anthropometric and metabolic outcomes in women with PCOS
  • Tetiana Yusko (UA)
    P.074 Suboptimal Vitamin D Levels in Polycystic Ovary Syndrome: A Retrospective Analysis of Incidence, Attitudes, and Practices (2021-2024)
  • Umida Ashurova (UZ)
    P.075 The Impact of Insulin Resistance on Abnormal Uterine Bleeding and Endometrial Hyperplasia: A Comparative Clinical Study
  • Mihaela Gavan (RO)
    P.076 Insulin resistance and ovarian morphology in women with polycystic ovary syndrome: a retrospective study of 80 cases
  • Kseniia Ostrovska (UA)
    P.077 Endometrial Condition and Insulin Resistance: Factors Potentially Reducing Fertility in Young Women with PCOS
  • Miljan Pupovac (RS)
    P.078 Association Between Glucose Curve Patterns and Insulin Resistance During Oral Glucose Tolerance Test in Women with Polycystic Ovary Syndrome
  • Peter Chedraui (EC)
    P.079 Adipose–Muscle Interactions: Triglyceride–Glucose Index (TyGi), Skeletal Muscle Mass, and Handgrip Strength in Midlife Women
  • Peter Chedraui (EC)
    P.080 Postmenopause Promotes Central Fat Gain and Lean Mass Loss in Midlife Women
  • Elene Gabunia (GE)
    P.081 Rapid Onset Obesity with Hypothalamic dysfunction, Hypoventilation and autonomic dysregulation (ROHHAD)
  • Rafaella Martins Boiati (BR)
    P.082 Nutritional and Clinical Profile of Pregnant Women Assisted at the Fetal Medicine Department of a reference hospital in Brazil
  • Rajlaxmi Mundhra (IN)
    P.083 Lipid -related indicators as predictor of Metabolic Syndrome in postmenopausal women: A Prospective Observational Study.
  • Carolina Piterschi (MD)
    P.084 Weight gain during pregnancy as a determinant of obesity in women of reproductive age
  • Gabriela Romano de Oliveira (BR)
    P.084B Associations of Vitamin D, IL-6, and Depressive Symptoms with Metabolic Syndrome in Postmenopausal Women
  • Zhenrun Zhan (CN)
    P.085 Predictive efficacy of different diagnostic criteria for obesity in osteoporosis and cardiovascular diseases
  • Vera Andreeva ()
    P.086 Study of the efficacy of the drug containing Dienogest/Estradiol Valerate in adolescents with recurrences of abnormal uterine bleeding by the dynamics of soluble apoptosis markers in blood serum
  • Vanessa Cunha Machado (BR)
    P.087 Increase in Body Mass Index and Gynecological Complaints in Children and Adolescents
  • Madinakhon Eshonkhodjaeva (UZ)
    P.088 Premature isolated thelarche (clinical case)
  • Elene Gabunia (GE)
    P.089 Severe Primary Hypothyroidism Presenting with Multicystic Ovarian Enlargement and Hyperprolactinemia in an Adolescent Girl.
  • Luciana Maestri Karoleski (BR)
    P.090 A new perspective on the Pubertal Development Scale (PDS) for epidemiological studies
  • Hidayat Mammadzada, MD (AZ)
    P.091 Misdiagnosed Mosaic Turner Case (XY pozitive)
  • Fatima Ester Gaitan Vallecillo (NI)
    P.092 Classic papillary carcinoma arising from thyroglossal cyst. About a case.
  • Massimo Giusti (IT)
    P.093 Prevalence of iodine deficiency or excess in pregnancy. Single-centre cross-sectional study in the Savona district since 2022 year.
  • Myroslav Maistrenko (UA)
    P.094 The Impact of Thyroid Dysfunction on Fertility and Reproductive Outcomes in Infertile Women: A Retrospective Study
  • Melany Makrridakis-Parra (CO)
    P.095 Prevalence of subclinical hypothyroidism in postmenopause and its relationship with muscle/joint pain: a study in Colombian women
  • Snezana Polovina (RS)
    P.096 Impact of obesity on bone quality in autoimmune thyroid disease: A study of middle-aged women
  • María Alejandra Tercero Arcia (NI)
    P.097 Ectopic, surprising, and very rare location of the thyroid gland
  • Negina Adkhamova (UZ)
    P.098 The Role of Genetic Testing in Endocrinology: A Case of Autoimmune Thyroiditis with Metabolic Syndrome Revealed through Exome Sequencing
  • Eleni Armeni (GB)
    P.099 Association Between Endometriosis and Dyslipidemia in Postmenopausal Women: A Retrospective Analysis from a University Menopause Clinic
  • Dzhulietta Avetisian (RU)
    P.100 New biomarkers in diagnosis of premature ovarian insufficiency based on the value of autoantibodies to steroidogenic enzymes
  • Nino Bezhanidze (GE)
    P.101 Gut Microbiome as a Biological Regulator of Female Reproductive Balance
  • Corina Cimpan (RO)
    P.102 Shared neuroendocrine mechanisms in Premenstrual Dysphoric Disorder (PMDD), Postpartum Depression (PPD), and Perimenopausal Affective Disorders: the role of progesterone, allopregnanolone, and cortisol
  • Vanessa Cunha Machado (BR)
    P.103 Menstrual Disturbances in Women with Congenital Adrenal Hyperplasia: A systematic review
  • Cecilia Xochitlalli Flores Granados (MX)
    P.104 Prevalencia de la insuficiencia ovárica prematura en pacientes atendidas en el servicio de biología de la reproducción humana de la umae hospital de gineco obstetricia no. 3 “dr. Víctor manuel espinoza de los reyes sanchez” del centro medico nacional “la raza” en el periodo de enero- diciembre 2024
  • Cecilia Xochitlalli Flores Granados (MX)
    P.105 Cansancio y dolor osteomuscular relacionados al climaterio como síntoma principal en mujeres mexicanas en un centro de tercer nivel de atención
  • Yingying Guo (CN)
    P.106 Acute intermittent porphyria correlated with menstruation: a single-centre retrospective study in China
  • Olena Gurzhenko (UA)
    P.107 Evaluation of the Hormonal Status in Women with Long-Term Complications after Cesarean Section
  • Lingling Jiang (CN)
    P.108 Estrogen Replacement Therapy can increase the recovery of endocrine ovarian function after Xenotransplantation of Human Ovarian Tissue in Nude Mice
  • Liudmyla Kalugina (UA)
    P.109 Concomitant thyroid disfunction in women with diabetes mellitus type 2 in chronic stress condition
  • Ayshan Khalilova (AZ)
    P.110 ACTH-dependent Cushing’s disease in an adolescent girl: diagnosis, surgical management, and long-term endocrine and reproductive recovery – a case report
  • Jolanda Refanya Labora (ID)
    P.111 Sleep, Stress and the Aging Ovary: Revisiting the HPA-HPG Axis Crosstalk in Female Endocrine Health
  • Mihai Loichita (RO)
    P.112 The Significance of LH Elevation in Women with Disorders of Ovulation Loichita Mihai 1, Loichita Adrian1, Petre Ion1, Bobora Razvan 1 , Furau Alexandru-Marius2, Petre Izabella1 1 “Victor Babes” University of Medicine and Pharmacy Timisoara, (ROMANIA) 2 "Vasile Goldiș" Western University of Arad, (ROMANIA)
  • Hidayat Mammadzada,MD (AZ)
    P.113 A case of forgotten Turner syndrome diagnosed at age 34 in a patient presenting with diabetes mellitus
  • Neli Nikolov (AE)
    P.114 Case Report: Burning Mouth Syndrome In Postmenopausal Women. Challenges Of Treatment
  • Elisabed Pkhaladze (GE)
    P.115 Combined Reproductive and Multiple Endocrinopathies in a Single Case
  • Kateryna Plaksiieva (UA)
    P.116 Turner Syndrome: A Case Report Highlighting Diagnostic and Therapeutic Challenges in Hormone Replacement Management
  • Ana Pruidze (GE)
    P.117 Journey from PCOS and multiple Endocrine comorbidities through the pregnancy
  • Liudmila Stavinskaia (MD)
    P.118 The impact of chronic viral hepatitis (hcv) on menstrual dysfunction in women of reproductive age
  • Stela Vudu (MD)
    P.119 Primary Ovarian Insufficiency as an Early Sentinel in Autoimmune Polyglandular Syndrome Type 2
  • Zhenrun Zhan (CN)
    P.120 The Protective Role of Appendicular Lean Mass in Osteoporosis Development Among Postmenopausal Type 2 Diabetes Patients
  • Sona Barsegian (RU)
    P.121 The impact of microplastics exposure on women’s reproductive health: current insights and future directions
  • Corina Cimpan (RO)
    P.122 Environmental Endocrine Disruptors and Female Reproductive Health: A Critical Appraisal of the Evidence
  • Ayshan Khalilova (AZ)
    P.123 Menstrual and Hormonal Disturbances in High- versus Low-Load Sports among Professional Female Athletes: A Systematic Review
  • Julianna Kopcha (UA)
    P.124 The Impact of the Microbiome on Hormonal Balance and Fertility: New Horizons in Reproductive Medicine
  • Zhenrun Zhan (CN)
    P.125 Predictive value of albumin-corrected anion gap for mortality in diabetic patients with severe heart failure
  • Armine Khroyan (AM)
    P.126 Resistant Ovary Syndrome: A Rare Cause of Infertility
  • Nadia Díaz Nakamura (ES)
    P.127 Delayed Diagnosis of Hyperprolactinemia: A Case Report
  • Armine Khroyan (AM)
    P.128 Evaluating Moderate Hyperprolactinemia: When is MRI Indicated?
  • Mariya Malyshko (BY)
    P.129 Evaluation of the effect of overweight and obesity on serum prolactin concentration in patients of reproductive age with moderate hyperprolactinemia
  • Sona Barsegian (RU)
    P.130 The role of kisspeptin in the pathogenesis and therapeutic potential in functional hypothalamic amenorrhea
  • Oksana Makarchuk (UA)
    P.131 Psychotraumatic Factors in Young Women with Stress-Induced Types of Ovarian Dysfunction
  • Gunel Musayeva (AZ)
    P.132 Congenital adrenal hyperplasia
  • Natalia Aganezova (RU)
    P.133 Assessment of the risk of negative quality of life declines in women with uterine fibroids without indications for surgical treatment
  • Edson Santos Ferreira-Filho (BR)
    P.134 Effectiveness of Tracking Cycle Mobile Applications as a Contraceptive Method: A Systematic Review
  • Natalie Gierat (US)
    P.135 Resolution of Migraine with Aura Following Intrauterine Device Placement: A Case Report of a 16-Year-Old Female and Maternal Correlation
  • Maia Parkauli (GE)
    P.136 Effectiveness and Safety of Mifepristone–Misoprostol Regimen for Second Trimester Pregnancy Termination
  • Ekaterina Antonova (RU)
    P.137 Reasons for premature IUS removal and ways to avoid this problem through counseling.
  • Ignacio Díaz Vega (CL)
    P.138 Comparative Outcomes of Mirena® vs Asertia® Levonorgestrel-Releasing Intrauterine Devices on Menstrual Bleeding, Dysmenorrhea, and Adverse Events in Women Treated for Contraception and Gynecological Disorders Between 2021 and 2025 at Hospital Guillermo Grant Benavente, Chile: A Retrospective Study
  • Nataliia Kosei (UA)
    P.139 The use of local hormone therapy as an effective management of abnormal uterine bleeding and dysmenorrhea in female military personnel and women involved in military conflict
  • Ana Carolina Mateus (PT)
    P.140 What matters the most: having one hand, size or flexibility? - from an Intrauterine Device (IUD) insertion perspective
  • Maria da Conceição Ribeiro Simões (BR)
    P.141 Iud insertion in the post-partum and post-abortion period in a maternity hospital in the western amazon, from january 2020 to december 2024
  • Luís Carlos Sakamoto (BR)
    P.142 Epidemiological Profile of Indications for Levonorgestrel Hormonal IUD Use
  • Gvantsa Apriamashvili (GE)
    P.143 Postpartum Contraception in Georgia: Are Women Receiving Adequate Guidance?
  • Solange Da Silva Silveira (BR)
    P.144 Choice of contraceptive methods in adolescents in an outpatient clinic in the western amazon, from 2020 to 2023
  • Raynara Gomes (BR)
    P.145 Media and its influence on young people’s contraceptive decisions
  • Iulian Pascariu (RO)
    P.146 Long-Acting Reversible Contraception in Adolescents: Challenges, Adherence, and Future Perspectives
  • Maria da Conceição Ribeiro Simões (BR)
    P.147 Choice of contraceptive methods in adolescents
  • Catarina Costa (PT)
    P.148 Profound Subdermal Implants' (SI) best way of removal - a 5 year experience in a tertiary hospital center
  • Danielle Mutta (BR)
    P.149 Acceptance of contraceptive methods after obstetric outcome in a public healthcare service.
  • Fatou Samb (SN)
    P.150 Evaluation of the postpartum contraceptive practice in a maternity hospital in Dakar
  • Alexandra Cristofor (RO)
    P.151 Contraception in Perimenopause: Between Pregnancy Prevention and Symptom Regulation
  • Pedro Pinto (PT)
    P.152 Satisfaction with the use of a combined oral contraceptive containing 14.2 mg estetrol / 3 mg drospirenone: The E4Satisfaction Study
  • Lucie Raskin (BE)
    P.153 Patients’ and gynecologists’ preferences for oral contraception in Europe: a discrete choice experiment and a call to participate.
  • Sitora Abdurakhmanova (UZ)
    P.154 Comparative assessment of pregnancy rates using embryo transfer media with and without hyaluronan
  • Sitora Abdurakhmanova (UZ)
    P.155 PRP therapy as an innovative method for restoring endometrial receptivity in patients with chronic endometritis in ART protocols.
  • Myroslav Maistrenko (UA)
    P.156 Information‑Resource Approaches to Predicting Successful Assisted Reproductive Technology (ART) Programs: Integration of Clinical, Embryological, and Molecular Parameters
  • Sijuan XU (CN)
    P.157 Presence and Characteristics of Microplastics in Uterine Fluid and Their Association with Recurrent Implantation Failure
  • Alexandra Axenova (RU)
    P.158 The Vaginal Microbiome in Spaceflight: Implications for Gynecologic Health, Immunity, and Reproductive Outcomes in Female Astronauts
  • Jane Boateng (NO)
    P.159 The relationship between growth factors and oocyte quality in human clinical studies
  • Fatima Ester Gaitan Vallecillo (NI)
    P.160 The common genetic key: Autoimmune Polyglandular Syndrome type III. Autoimmune
  • Jose Maria Soares-Jr (BR)
    P.161 Melatonin Enhances Glutathione Peroxidase Activity and Reduces Oxidative Stress in Cryopreserved Ovarian Transplants: A Rat Model Study
  • Eriko Terasawa (JP)
    P.162 Relationship between Resting Heart Rate and Menstrual-Associated Symptoms Across Menstrual Phases in Daily Life
  • Mihaela Burac (MD)
    P.163 The cytokine profile of the endometrial fluid in primary infertility women
  • Basa Gegeshidze (GE)
    P.164 Late Diagnosis of Klinefelter Syndrome: A Challenge for Fertility Management
  • Katarzyna Jankowska (PL)
    P.165 Coordinator of Procreative Health
  • Estefania Mora Lorente (ES)
    P.166 Repeated Empty Follicle Syndrome in a Young Woman with Normal Ovarian Reserve: Possible Role of FSH and LH Receptor Alterations
  • Taisiia Yurchuk (PL)
    P.167 Rescue Oocyte IVM: The Role of IGF-1, EGF, and dbcAMP in Restoring Cumulus–Oocyte Communication
  • MUHAMMAD AZRAI ABU (MY)
    P.168 Dual Trigger and In-Vitro Fertilisation Outcome: A Single Hospital Experience
  • Mery Natroshvili (GE)
    P.169 Luteal Phase Support in Ovulation Induction Cycles: Current Evidence and Controversies
  • Fatma Zaiter (TN)
    P.170 Ovarian Stimulation and the Occurrence of Borderline Ovarian Tumors: Results from a Retrospective Monocentric Study
  • Niko Koridze (GE)
    P.171 Spontaneous Bilateral Theca Lutein Cysts with Ascites in a Singleton Pregnancy Without Ovulation Induction: A Rare Case Report
  • Bogdan-Nicolae Andronic-Niculescu (RO)
    P.172 Deep endometriosis and infertility: prognostic factors
  • Alexandra Baușic (RO)
    P.173 Fertility Outcomes Following Endometriosis Surgery: The Impact of Age, AMH, EFI Score, and Surgical Approach
  • Eglantina Dema (AL)
    P.174 Successful Twin Pregnancy Following IVF in a Patient with Right Adnexectomy and Left Tubectomy: A Rare Case Report
  • Dzhafarova Makhluga (RU)
    P.175 Respiratory Viral Infection Associated Thoracic Endometriosis: case report
  • Ayako Muraoka (JP)
    P.176 Serum-derived extracellular vesicles as biomarkers for predicting pregnancy on assisted reproductive technology in patients with endometriosis
  • Hanna Surmann (DE)
    P.177 Micro-RNA (miRNA) in Endometriosis-Related Infertility: A Systematic Literature Review
  • Tomasz Milewicz (PL)
    P.178 Plasma AMH level is lower and FSH is higher in AITD poor responder women
  • Miljan Pupovac (RS)
    P.179 When Less Is More: Intrauterine Insemination as a Viable First-Line Option in Hypogonadotropic Hypogonadism
  • Wei Zhang (CN)
    P.180 Challenges for Induced Ovulation of Infertile Women with Idiopathic Hypogonadotropic Hypogonadism
  • Mladen Anđić (RS)
    P.181 The Impact of Insulin Resistance on Intrauterine Insemination Outcomes
  • Mladen Anđić (RS)
    P.182 The case series of the outcomes of intrauterine insemination in patients with diminished ovarian reserve
  • Andreia Fernandes (ES)
    P.183 Treatment with a patented 3.6:1 myo-inositol/d-chiro-inositol, antioxidants and probiotics to increase pregnancy chances in women with advanced maternal age and low ovarian reserve
  • Andreia Fernandes (ES)
    P.184 Supplementation with 3.6:1 myo-inositol/d-chiro-inositol, antioxidants and probiotics to improve oocyte quality and increase pregnancy chances in women with history of art failures without PCOS
  • Terras Khaled (TN)
    P.185 What Really Drives Blastulation in PCOS?
  • Alexandra Axenova (RU)
    P.186 Fertility Preservation in Young Oncology Patients: Reproductive Outcomes Across Cancer Types — A Literature Review with Case Illustrations
  • Laura Daniela Giraldo Martínez (CO)
    P.187 Isolated torsion of the fallopian tube associated with hematosalpinx, a rare and pre-surgically challenging diagnosis. Report of two clinical cases
  • Muqing Gu (CN)
    P.188 Advances in preservation of ovarian function and fertility in children and young women
  • Muqing Gu (CN)
    P.189 Hypoxia-preconditioned hUCMSCs improve function of cryopreserved ovarian tissue through the Akt/HIF-1α/VEGF pathway
  • Sofia Jacques (PT)
    P.190 Reproductive Counseling and Fertility Preservation Outcomes in Turner Syndrome
  • Jarosław Kaczyński (PL)
    P.191 Efficiency of Oocyte Vitrification and Ovarian Tissue Cryopreservation Following Oncological Treatment.
  • Kseniia Kondrashkina (RU)
    P.192 Fertility Preservation in Young Oncology Patients: Reproductive Outcomes Across Cancer Types
  • Vyjayanthi Srinivasan (IN)
    P.193 Questionnaire-Based Survey to map the scope and awareness of fertility preservation in the CAYA population and reproductive age group in an oncology clinic at a tertiary hospital in India
  • Natália Vasconcelos (BR)
    P.194 The Landscape of Assisted Reproductive Technology in Brazil: Distribution, Performance, and Regional Inequalities
  • Natália Vasconcelos (BR)
    P.195 Temporal Trends in Elective Oocyte Cryopreservation and Age-Related Outcomes: A 17-Year Experience in Southern Brazil
  • Bartłomiej Wojtasik (PL)
    P.196 Comparison of Invasive and Non-Invasive Preimplantation Genetic Testing
  • Elisa Simarro Suárez (ES)
    P.197 Post-Retrieval Ovarian Abscess in Endometriosis: Case Report and Practical Lessons
  • Luciana Lamarão Damous (BR)
    P.198 Multispecies Decellularized Ovarian Extracellular Matrix (dECM) as Scaffolds for Potential Pre-Clinical Trials Applications
  • Nadine Massiah (NO)
    P.199 The relationship between geographical location and access to fertility preservation treatment for females with cancer
  • Raluca Mogos (RO)
    P.200 Physician–Patient Communication in Pregnancy Decision-Making Among Women Over 40: Insights from Private Practice
  • Iavor Vladimirov (BG)
    P.201 Evaluation of Serum Anti-Müllerian Hormone (AMH) Values for 28,016 Bulgarian Women: Prognostic Statistical Model of Age Specific AMH Declining
  • Martin Vladimirov (BG)
    P.202 IVF Mobile – More Convenient and Closer to the Patient
  • Kátia Caroline Ferreira Matias (BR)
    P.203 Methods used for uterine emptying in a maternity hospital in the western amazon from january 2021 to december 2024
  • Diana Mitriuc (MD)
    P.204 Clinical–Genetic Predictive Model for Recurrent Pregnancy Loss: The Impact of Non-Classical Thrombophilic Mutations
  • Diana Mitriuc (MD)
    P.205 Integrating Non-Classical Thrombophilic Variants into Predictive Modeling of Recurrent Pregnancy Loss
  • Revenko Oleh (UA)
    P.206 Immunohistochemical characteristics of endometrium in women with early pregnancy loss and adenomyosis
  • Diana Mitriuc (MD)
    P.207 Clinical Impact of Thrombophilic Gene Variants in Women with Recurrent Pregnancy Loss
  • Kamola Abdullajonova (UZ)
    P.208 Successful Organ-Preserving Treatment of an Isthmic Pregnancy in the Area of a Uterine Scar: A Clinical Analysis
  • E. Cansu Cevik (US)
    P.209 Single- vs Double-Dose Methotrexate for Ectopic Pregnancy: A Prospective Randomized Comparison
  • Fatou Samb (SN)
    P.210 Management of extra-uterine pregnancy at the gynecology-obstetrical department of the Dakar social hygiene institute: about 60 cases collected between January 1, 2019 and July 31, 2021
  • Arzu Akpinar (TR)
    P.211 Video-reflected evaluation of humanistic nursing theory-based care given to women who had pregnancy termination: Action research
  • Alexandra Axenova (RU)
    P.212 Preimplantation Genomic Risk Profiling and Mitochondrial Health in ART: Toward Personalized Embryo Selection and Female Reproductive Longevity
  • Ramona Dragomir (RO)
    P.213 Cerebral Malformations Detected in the Third Trimester of Pregnancy: Clinical and Imaging Insights
  • Roxana Matasariu (RO)
    P.214 Challenges in Prenatal Ultrasound Diagnosis of Rubinstein–Taybi Syndrome: A Case Report and Comprehensive Literature Review
  • Vladislava Khalenko (RU)
    P.215 Unraveling the Maternal Metabolic Profile: Vitamin and Mineral Imbalances in Cases of Folate-Sensitive Fetal Anomalies
  • Nigora Tursunova (UZ)
    P.216 Varicose disease in pregnant women includes varicose enlargement of the hemorrhoidal veins, external genital veins, and pelvic veins.
  • Nigora Tursunova (UZ)
    P.217 Varicose veins and lower extremities in pregnant women.
  • Gemma Gassó Perales (ES)
    P.218 Intrahepatic Cholestasis of Pregnancy: A Single-Center Retrospective Analysis of Obstetric and Neonatal Outcomes
  • Svitlana Heryak (UA)
    P.219 Early markers of perinatal disorders in pregnant women with comorbid pathology
  • Miriam Mayal Etreros (ES)
    P.220 Electrohysterography as a non-invasive tool to predict the success of external cephalic version: preliminary results from a pilot study.
  • Alvaro Monterrosa-Castro (CO)
    P.221 Non-Flourishing Positive Mental Materna Health: The Role of Maternal–Fetal Attachment and Depressive Symptoms in a Cross-Sectional Study
  • Iaisa Helena Faria Ribeiro Xavier (BR)
    P.222 Syndrome of amniotic flange in pregnant accompanied in an ambulatory of the western amazon: case report
  • Natalya Nadirkhanova (UZ)
    P.223 Prospective study on the effectiveness of a comprehensive diagnostic and management model in placenta previa
  • Maria-Elena Nita (RO)
    P.224 Genital infections – pregnancy edition
  • Elena Alekseenkova (RU)
    P.225 Serum cytokine profile in women with type 1 diabetes in the third trimester of pregnancy and their newborns
  • Solange Da Silva Silveira (BR)
    P.226 Complications of type 2 diabetes mellitus in a pregnant woman treated at a hospital in the western amazon: case report
  • MARIA ANASTASIA DASKALAKI (GR)
    P.227 Myo-inositol supplementation and prevention of gestational diabetes mellitus
  • Fatima Gaitan Vallecillo (NI)
    P.228 Hypercalcemia in pregnancy
  • Sopo Javelidze (GE)
    P.229 Post-bariatric challenges during pregnancy
  • Oxana Koliadina (RU)
    P.230 Title: Continuous Glucose Monitoring in Pregnant Women with Gestational Diabetes Mellitus: Real-World Experience
  • Samira Mirrakhimova (UZ)
    P.231 Influence of Obesity in Pregnant Women on Pregnancy Outcomes and Fetal Condition
  • Patrizia Monteleone (IT)
    P.232 Diabetes insipidus in pregnancy: a case report
  • Vira Pyrohova (UA)
    P.233 Evaluation of outcomes of the first pregnancy in women with dyshormonal gynecological pathology (pcos, aub, hyperprolactinemia, endometriosis).
  • Laura Seco (ES)
    P.234 Histamine and Pregnancy: The Role of DAO and Immune Tolerance in Reproductive Success
  • Radmila Sparic (RS)
    P.235 Unmasking Primary Hyperparathyroidism in Early Pregnancy: A Diagnostic and Therapeutic Challenge
  • Lina Bahniy (UA)
    P.236 Vaccination During Pregnancy: An Analysis of Awareness and Attitudes Among Pregnant and Postpartum Women
  • Lina Bahniy (UA)
    P.237 Perineal massage for prevention of obstetric lacerations
  • Irida Dajti (AL)
    P.238 "Maternal Nutrition in Pregnancy: Myths Versus Facts"
  • Ramona Dragomir (RO)
    P.239 Clinical Impact of Maternal Vitamin D Deficiency in Pregnancy
  • Daria Koleva (BG)
    P.240 Lumbosacral and Pelvic Pain in Pregnancy: Prevalence, Risk Factors, and the Effectiveness of Non-Pharmacological Interventions
  • Jehona Luta (XK)
    P.241 Utilization of Prenatal Health Services and Perceived Gaps in Psychological Support Among Pregnant Women in Kosovo
  • Mitsuki Nojima (JP)
    P.242 Development of a Stressor Scale for Mothers of Infants Admitted to the Neonatal Intensive Care Unit Verification of Content Validity
  • Simin Taavoni (IR)
    P.243 Physiologic Labour Pain and Anxiety Managemt by Watching Nature Sights: Randomized Clinical Control Trial
  • Yukie Tanaka (JP)
    P.244 Postpartum Mental Health Screening and Practical Support for Mother-to-Infant Bonding Formation by Nursing Professionals in the First Two Weeks Postpartum
  • Razaz Wali (SA)
    P.245 The prevalence and determinants of unintended pregnancy among pregnant women attending antenatal clinics in the primary health care at KAMC- Jeddah.
  • Carolina Araujo Pereira (BR)
    P.246 Case report: delivery in dichorionic diamniotic twin pregnancy with eight-week placental retention
  • Carolina Araujo Pereira (BR)
    P.247 Isthmo-cervical incompetence in an amazonian context that evolved successfully without cerclage
  • Tamy Colonetti (BR)
    P.248 Impact of Cervicovaginal microbiota dysbiosis on Preterm Birth: Systematic Review and Meta-Analysis
  • Iaisa Helena Faria Ribeiro Xavier (BR)
    P.249 Pregnant woman treated at a hospital in western amazonia: case report
  • Nikola Lyubenov (US)
    P.250 Uterine Rupture in the Second Trimester: A Rare Case at 14 Weeks of Gestation
  • Unno Taeko (JP)
    P.251 Use of Wearable Devices for the Prediction of Preterm Birth in Pregnancy: A Literature Review
  • Edvard Akhmadiev (UZ)
    P.252 Comprehensive Model for Early Screening of Preeclampsia in Pregnant Women with Clinical Risk Factors
  • Guldjahan Babadjanova (UZ)
    P.253 Liver dysfunction as a predictor of severe preeclampsia: a prospective study
  • Mariam Khutsishvili (GE)
    P.254 Eosinophils as a new biomarker in the prevention of preeclampsia
  • Karimova Lutfiya (UZ)
    P.255 FLT-1 (VEGFR-1) Gene Polymorphism rs4769613 as a Genetic Marker for Differentiating Preeclampsia and COVID-19–Related Preeclampsia-Like Syndrome
  • sergey Mihalin (RU)
    P.256 Gestational complications (major obstetric syndromes) - the role of genetic thrombophilia.
  • Swati Tomar (IN)
    P.257 Exhaled Breath Carbon Monoxide as a Predictor of Pregnancy Outcomes: A Pilot Study
  • Umida Ashurova (UZ)
    P.258 Risk Factors for Failed Induction of Labour in Women with Gestational Diabetes Mellitus: A Critical Analysis
  • Tanja Milić-Radić (BA)
    P.354b Endometrial polyp in premenopausal and postmenopausal patients
  • Rodica Catrinici (MD)
    P.259 Impact of Gestational Diabetes Mellitus on Fetal Growth and Perinatal Outcomes: A Retrospective Study
  • Tabinda Dugal (QA)
    P.260 Title: Fetal Anomalies in Pregnancies Complicated by Pre-existing Type 2 Diabetes – A Case-based Review
  • Song He (SG)
    P.261 Description of a pilot care model - KKH Gestational Diabetes Group Prenatal Care (KKGDG)
  • Ramiya Pratheepan (GB)
    P.262 Association between Cerebroplacental Ratio and Cord Blood Red Blood Cell Deformability: Insights Into Fetal Circulatory Adaptation
  • Ekaterina Tugay (RU)
    P.263 Magnesium and Vitamin D status in early pregnancy as predictors of Gestational Diabetes: prospective cohort protocol with interim findings
  • Elena Alekseenkova (RU)
    P.264 Sonographic prediction of neonatal body composition measures with fetal fractional limb volume in pregestational and gestational diabetes mellitus
  • Raluca Maria Haba (RO)
    P.265 Vaginal Birth After Cesarean in Romania: Clinical Outcomes and Women’s Perspectives
  • Raluca Maria Haba (RO)
    P.266 Placental Alterations and Their Clinical Impact in Pregnancies Complicated by Intrauterine Growth Restriction
  • Dorina Adelina Minciuna (RO)
    P.267 Evaluation of NT-proBNP and GDF-15 as Combined Biomarkers for the Diagnosis and Prognostic Stratification of Fetal Growth Restriction
  • Olena Gnatko (UA)
    P.268 Anaemic Syndrome in Pregnant Women with Helicobacter Pylori
  • Sahadete Shala (RS)
    P.269 Psoas abscessafter cesarean section birth :A case report
  • Rose Angelica Estella-King (PH)
    P.270 Delayed Interval Delivery of Twins after Rupture of Membranes in a Patient who underwent Radical Trachelectomy
  • Hanna Mostova (UA)
    P.271 Pregnancy and childbirth in the woman with monochorionic diamniotic twins. Antenatal death of the second fetus.
  • Gerson Jhoseph Lima dos Santos (BR)
    P.272 Conjoined twin pregnancy in a didelphic uterus with thoraco-omphalopagus fetuses treated in a hospital in the amazon region: case report
  • Rose Angelica Estella-King (PH)
    P.274 Maternal and Neonatal Outcomes, and Prevalence of Primary Cesarean Section for Dystocia after the Implementation of the New Consensus Guidelines in a Tertiary Medical Center in the Philippines
  • Miriam Mayal Etreros (ES)
    P.275 External Cephalic Version (ECV): Literature Review and Our Center's Experience.
  • Samira Mirrakhimova (UZ)
    P.276 Cesarean Section: Pros and Cons. Clinical and Analytical Review
  • Valerija Raksa (LV)
    P.277 Maternal and Neonatal Complications after Cesarean Section by Delivery Urgency and Plurality, Accounting for Gestational Age
  • Roxana Matasariu (RO)
    P.278 Pyoderma Gangrenosum, a Challenging Postpartum Diagnosis—Case Report and Literature Review
  • Nigora Muratova (UZ)
    P.279 Prevention of hypocoagulation in pregnant women with recurrent miscarriages
  • Lara Takayama (BR)
    P.280 Comparison of subcutaneous insulin and intravenous insulin for intrapartum glycemic control in insulin-dependent women: A Systematic Review and Meta-analysis
  • Guldjahan Babadjanova (UZ)
    P.281 Risk factors for excessive weight gain in pregnant women
  • Oksana Makarchuk (UA)
    P.282 Pregnancy and overweight: the role of endothelial dysfunction in the development of gestational complications
  • Lovely Bolo (PH)
    P.283 Maternal Mortality Review by Three-Delay Model: A Three-Year Retrospective Study in Ilocos Norte
  • Madinakhon Eshonkhodjaeva (UZ)
    P.284 Thrombocytic pathologies during pregnancy and their hemorrhagic indications
  • Mariam Khutsishvili (GE)
    P.285 The Hidden Burden: Traumatic Birth Experiences and Postpartum Depression in Georgian Women
  • Maria-Elena Nita (RO)
    P.286 Postpartum hemorrhages – a real emergency
  • Oksana Andriiets (UA)
    P.287 Awareness of Adolescent Girls and Their Parents Regarding Gynecological Health: Age-Related Differences
  • Inna Bachynska (UA)
    P.288 Duplicated uterus and hemivaginal or hemicervical atresia accompanied by ipsilateral renal agenesis – our experience
  • Macarena Castiglione (CL)
    P.289 Herlyn-Werner-Wunderlich Syndrome Presenting as Refractory Primary Dysmenorrhea: A Case Report
  • Florin Isopescu (RO)
    P.290 Contributions to the study of menarcheal age in Romania
  • Victoria Monterrey Perera (ES)
    P.291 Lipschütz Ulcer in the Gynecology Emergency Department at La Fe University Hospital: A Case Series
  • Iraida Snigur (MD)
    P.292 The Role of Holistic Non-Pharmacologic Therapy in Primary Dysmenorrhea in Adolescents
  • Justina Stasiulytė (LT)
    P.293 Heavy menstrual bleeding management in adolescents with von Willebrand disease: case report.
  • Yauheniya Tsikhanovich (BY)
    P.294 Diagnosis and management of congenital anomalies of the female genital tract in pediatric patients
  • Lijing Guo (CN)
    P.295 Sexual Health in Breast Cancer: 2000–2025 Evidence Synthesis and Multidisciplinary Pathways
  • Ayshan Khalilova (AZ)
    P.296 Late diagnosis of Turner syndrome (45,X0) at the age of 23: a case report highlighting delayed reproductive and endocrine evaluation
  • Hidayat Mammadzada, MD (AZ)
    P.297 Swyer Syndrome: Case Report
  • Eliana Nahas (BR)
    P.298 Assessment of the Effectiveness of a Non-Hormonal Vaginal Moisturizer on Sexual Function in Postmenopausal Women with Breast Cancer: A Randomized Clinical Trial
  • Kiyoko Naito (JP)
    P.299 Characteristics of Women Who Can Be Guided in Pelvic Floor Muscle Training Using Digital Devices from Remote Locations.
  • Vibeke Salvesen (NO)
    P.300 Sexual Function in Norwegian Women with Chronic or Previous Disease: A Descriptive Cross-Sectional Study
  • Okayama Hisayo (JP)
    P.301 Subjective Symptoms and Autonomic Nervous Activity in Japanese Premenopausal Women during the Menstrual and Follicular Phases
  • Vesela Karamisheva (BG)
    P.302 Title: Family History of Estrogen-Dependent Diseases as a Risk Factor for Endometrial Polyps: A Prospective Study
  • Martin Odhiambo (KE)
    P.303 Recurrent endometriosis-associated ascites with thoracic endometriosis: A case report and review of literature
  • Justina Stasiulyte (LT)
    P.304 A rare case of McCune-Albright syndrome diagnosed according to clinical manifestation
  • Vladislava Khalenko (RU)
    P.305 A Nanocomposite Hydrogel with Liposomal G-CSF as a Novel Regenerative Therapy for Refractory Endometrium
  • Nataliia Kosei (UA)
    P.306 Determination of the endometrial microbiome using 16S rRNA gene sequencing
  • Anna Markosyan (AM)
    P.307 Expression of Apoptosis Regulators NF-κB, Bcl-2, and Caspase-8 in the Endometrium of Women with External Genital Endometriosis and Chronic Endometritis
  • Garima Kachhawa (IN)
    P.308 Quality of Life after Levonorgestrel Intra-uterine System in Women with Haematological Disorders
  • Victoria Michaels Lopez (FR)
    P.309 Prevalence, impact, and management of Heavy Menstrual Bleeding (HMB) among French women: a mixed-methods cross-sectional study
  • Gabriela Vanin de Moraes (BR)
    P.310 Prevalence of anemia in women undergoing abdominal hysterectomy for leiomyoma in the post-pandemic period
  • Fedora Ambrosetti (IT)
    P.311 Vulvodynia integrative approach with acupuncture – case report and study protocol for clinical applications
  • Elena Ivanova (MD)
    P.312 Clinical and Ultrasound Prediction of Deep Infiltrating Endometriosis
  • Dejan Mihajlovic (RS)
    P.313 Mental burden of dysmenorrhea in young serbian females
  • Elisa Simarro Suárez (ES)
    P.314 Clinical Utility of Transperineal Ultrasound in Obstetric Anal Sphincter Injuries: A 9-Year Experience (2016–2024)
  • Rafał Watrowski (DE)
    P.315 Captive uterus syndrome: analysis of clinical manifestations and risk factors, diagnostic criteria, and staging proposal
  • Nadejda Codreanu (MD)
    P.316 Endometriosis Fertility Index in Deep Infiltrating Endometriosis: A Comparative Study
  • María del Rocío Expósito Fernández (ES)
    P.317 Left-Sided Spontaneous Pneumothorax in an Adolescent with Suspected Catamenial Pneumothorax: A Case Report
  • Anna Markosyan (AM)
    P.318 Diagnostic potential of saliva in non-invasive detection of endometriosis based on current evidence
  • Khatty Neves (BR)
    P.319 Complete Regression of Giant Ovarian Endometriomas Following Treatment with Gestrinone Implant: "A Case Report.”
  • Laura Pivazyan (RU)
    P.320 Oxidative Stress and Somatic Mutations in Endometriosis: next-generation sequencing data
  • Maja Pusic Novak (SI)
    P.321 Assessment of Growth Arrest-Specific Protein 6 as a Biomarker Candidate in Endometriosis
  • Alexandra Robu (RO)
    P.322 A review and meta-analysis of vitamin d as the iceberg in endometriosis
  • Daniela Angerame Yela Gomes (BR)
    P.323 Comparative Effectiveness of Dienogest and Desogestrel in the Treatment of Endometriosis: A Retrospective Cohort Analysis Considering Racial and Ethnic Differences
  • Urša Kešar (SI)
    P.324 AKR1C3 as a potential target for new treatment options in endometriosis
  • Min Young Kim (KR)
    P.325 Effects of dienogest and combined oral contraceptives treatment on small ovarian endometriomas
  • Réka Kollarics (DE)
    P.326 Dysmenorrhea and dyspareunia are not diagnostic for endometriosis
  • Larysa Malanchuk (UA)
    P.327 The place of immunotherapy in the complex treatment of ovarian endometriomas based on the results of dynamic assessment of the subpopulation composition of immunocompetent cells in peripheral blood.
  • Maria-Angeles Martínez-Zamora (ES)
    P.328 Overall usefulness of desogestrel as a safe long-term contraceptive treatment for endometriosis patients: what can we expect?
  • Natália Rye Makyama (BR)
    P.329 Evaluation of the Response to Surgical Treatment in Women with Endometriosis
  • Tommaso Simoncini (IT)
    P.330 Copper-targeted treatment reduces fibrosis in experimental endometriosis
  • Tommaso Simoncini (IT)
    P.331 Estetrol attenuates fibrosis-related gene expression and modulates β-catenin signaling in an experimental model of endometriosis
  • Lagiya Abdullaeva (UZ)
    P.332 Correction of Psychoemotional Disorders in Perimenopausal Women with Uterine Fibroids: Clinical Efficacy of Sulpiride Therapy
  • Lagiya Abdullaeva (UZ)
    P.333 Prediction and Morphological Mechanisms of Chronic Endometritis Formation in Reproductive-Age Women with Uterine Fibroids
  • Arsyad Alfathdry (ID)
    P.334 Comparative Operative Outcomes Between Laparoscopic and Open Myomectomy: Insights from a Tertiary Center Experience
  • Shayman Gadimova (AZ)
    P.335 Surgical Management of Fibroid Necrosis During Early Pregnancy: Two Case Reports
  • Nino Kupreishvili (GE)
    P.336 The Potential Impact of Protein Supplements on Uterine Fibroid Growth: A Clinical Case Report
  • Nigora Muratova (UZ)
    P.337 Prevention of uterine fibroids recurrence after surgical treatment
  • Kamilė Piesliakaitė (LT)
    P.338 Rare presentation of smooth muscle tumor of uncertain malignant potential: a case report
  • Antonio Ramírez Osuna (ES)
    P.339 GnRH Antagonist with Add-Back in Uterine Fibroids: Real-World Experience with Ryeqo®
  • Hye Jin Chang (KR)
    P.340 Changes in AMH Compared to Size After Sclerotherapy in Patients with Endometrioma
  • Vesela Karamisheva (BG)
    P.341 Synchronous Primary Ovarian and Appendiceal Carcinomas: A Case Report and Review of the Literature
  • Liliya Koleva (BG)
    P.342 Colonic Involvement in Ovarian Carcinoma: A Case Report and Review of Diagnostic Challenges Between Metastasis and Synchronous Primaries
  • Claudia Lagos Valenzuela (CL)
    P.343 Difficult-to-Diagnose Adnexal Mass: A Case of Struma Ovarii
  • Diana Mitriuc (MD)
    P.344 Atypical localization of a serous ovarian cystadenoma: case report and management
  • Alfonso Duque Frischkorn (ES)
    P.345 Efficacy and Safety of a Proprietary Vaginal Gel Containing 4.5% Lactic Acid and Glycogen in Women with Clinical Symptoms Suggestive of Bacterial Vaginosis: The Multicenter Clinical Study ZELTECT
  • Laura Daniela Giraldo Martínez (CO)
    P.346 Vulvar Leiomyoma: A Diagnostic Challenge
  • Madalina Ioana Marza (RO)
    P.347 Dermatology Meets Gynecology: Navigating Pigmented Vulvar Lesions
  • Khatty Neves (BR)
    P.348 Ablative Radiofrequency Combined with Exosomes for the Treatment of Vulvar Lichen Sclerosus: Case Series
  • Tina Ellinor Rosland (NO)
    P.349 Vulvar leiomyoma – A case report
  • Ana Ardashelia (GE)
    P.350 The Link Between Adenomyosis and Infertility: New Perspectives
  • Ekaterina Orekhova (RU)
    P.351 A connection between adenomyosis and subfertility
  • Valeriia Seregina (RU)
    P.352 Β-adrenoreceptors types 1 and 2 in the diagnosis of pain syndrome in patients with different forms of adenomyosis
  • Daniela Yela (BR)
    P.353 Evaluation of adenomyosis treatment with dienogest and levonorgestrel-releasing intrauterine system
  • Daria Kartashova (UA)
    P.354 The Role of Microsatellite Instability (MSI) of the Genome in the Development of Polyps and Hyperplastic Processes in the Endometrium of Women with Infertility
  • Corina Darii (MD)
    P.355 Genital Herpes in Young Moldovan Women: Epidemiological and Behavioral Trends
  • Lesia Demianenko (UA)
    P.356 Extracellular vehicles complex derived from the mesenchymal stromal cells of different tissue origin is effective for the vulvovaginal atrophy management.
  • Luciana Lamarão Damous (BR)
    P.357 Analysis of Estrogen-Dependent Tissues on Rats with Frozen-Thawed Ovarian Grafts Treated with Adipose Tissue-Derived Stem Cells
  • Andjela Boskovic (RS)
    P.358 Menopausal hormonal therapy: timing and safety!
  • Ayse Nur Cakir Gungor (TR)
    P.359 COMPARISON of ZONULIN LEVELS of PREMENOPAUSAL and POSTMENOPAUSAL WOMEN
  • Maria Franchina (AR)
    P.360 Beyond Age: Cardiometabolic and Inflammatory Burden in Premature Ovarian Insufficiency
  • Maria Yarmolinskaya (RU)
    P.361 In vitro Model of Premature Ovarian Insufficiency Based on Cyclophosphamide-Induced Mitochondrial Dysfunction in Granulosa Cells
  • Salomé Barrios-Diaz (CO)
    P.362 Job Dissatisfaction in Colombian Postmenopausal Women: Evaluation with the Overall Job Satisfaction Scale
  • Kitti Chattrakulchai (TH)
    P.363 Prevalence, Risk Factors, and Quality of Life Impact of Lower Urinary Tract Symptoms in Postmenopausal Women: A Community-Based Cross-Sectional Study in Urban Communities
  • Isabel Jiménez-Romero (CO)
    P.364 Psychological symptoms of menopause are linked to excessive daytime sleepiness in Afro-Colombian women
  • Kseniia Kondrashkina (RU)
    P.365 Personalized Approaches to Menopause and Aging: Hormone Therapy, Biomarkers, and Quality of Life
  • Cristina Laguna Benettti-Pinto (BR)
    P.366 The Perimenopausal Period as a Critical Window for Mental Health Vulnerability: Insights from the MARIE Project in Brazil
  • Profire Liliana (MD)
    P.367 Pharmacological Treatment of Vasomotor and Psycho-Emotional Symptoms in Menopause
  • Alvaro Monterrosa-Castro (CO)
    P.368 Association between occupational well-being and electronic cigarettes use in Colombian postmenopausal women
  • Tessa Morgan (AU)
    P.369 Experiences of the first two years in a new, unique multispecialist Hormone and Mood Clinic at The Menopause Hub, The Royal Hospital for Women, Randwick
  • Antonia Muñoz (CL)
    P.370 Vaginal obliteration with urinary obstruction in a postmenopausal woman: A Case Report and literature review
  • Elena Pavicic (CH)
    P.371 Catecholamines, cortisol, and climacteric symptoms: neurostress profiling in postmenopausal women – a cross-sectional observational study
  • Vira Pyrohova (UA)
    P.372 Assessment of the relationship between thyroid dysfunction and the severity of menopausal disorders
  • Aneta Sima (MK)
    P.373 The Severity Of Menopausal Symptoms In Correlation With Body Mass Index In Perimenopause
  • Claudio Soares (CA)
    P.374 Identifying sleep associations in women across five countries: a global smartwatch-based study
  • Liudmila Stavinskaia (MD)
    P.375 The use of hrt in women with compensated hypothyroidism in perimenopause
  • Nina Tirso (BA)
    P.376 Unmet Need for Hormone Therapy: A Cross-Sectional Study of Perimenopausal Depression in Women from a Developing Country
  • Yalong Tu (CN)
    P.377 Machine Learning-Based Prediction of Clinical Outcomes in Elderly Diabetics after Severe Myocardial Infarction
  • Chanakan Youkhong (TH)
    P.378 Translation and Psychometric Validation of the Thai Version of the Hot Flash-Related Daily Interference Scale (HFRDIS)
  • Ioana Ardelean (RO)
    P.379 Menopause – Qualitative Study in the West Side of Romania
  • Adishah Çerma (AL)
    P.380 Lipid profile in a patient with Premature Ovarian Insufficiency- The role of HRT and Statins
  • Luiz Fernando Dardis (BR)
    P.381 Cardiovascular risk in postmenopausal women: anxiety as an under-recognized factor
  • Carolina Furtado Macruz (BR)
    P.382 Assessment of clinical and metabolic parameters in women after natural or surgical menopause from 2022 to 2024 in a public hospital in São Paulo and their clinical repercussions
  • Olívia Naves de Andrade (BR)
    P.383 Self-Care Agency and Cardiovascular Profile in Women During the Climacteric Period
  • Claudio Lera Orsatti (BR)
    P.384 Circulating HSP27 as a Protective Biomarker for Cardiovascular Risk in Postmenopausal Women: Evidence from a Cross-Sectional Study
  • Miljanka Vuksanovic (RS)
    P.385 Effects of Hormone Replacement Therapy on Lipid and Glucose Metabolism in Postmenopausal Women with Type 2 Diabetes and Hyperlipidemia
  • Nilufar Bakoeva (UZ)
    P.386 Epidemiology of Menopausal Musculoskeletal Syndrome (MMSS) in Uzbekistan: First Population-based Study Across Three Climatic Regions
  • Yuna Kim (KR)
    P.387 Predicting Low Bone Mineral Density in Premenopausal Women Using Machine Learning: A Study Based on the Korea National Health and Nutrition Examination Survey
  • Liliya Koleva (BG)
    P.388 Title: Analysis of Risk Factors and Awareness of Osteoporosis Among Women
  • Paula Briggs (GB)
    P.389 Efficacy of elinzanetant in VMS associated with endocrine therapy: subgroup analyses of the Phase III OASIS-4 trial
  • Cecilia Caetano (CH)
    P.390 Effect of elinzanetant on VMS associated with natural menopause, surgical menopause, or endocrine therapy
  • Tamy Colonetti (BR)
    P.391 Effects of Green Tea on Lipid Profile in Postmenopausal Women: Systematic Review and Meta-analysis
  • Liliana Daniela Esparragoza Salazar (MX)
    P.392 Clinical trial: Evaluation of Nano Omega-5 in perimenopause and early postmenopausal patients: on quality of life, sleep quality and depression.
  • Li Ling (CN)
    P.394 Live Lactobacillus Capsule for Vaginal Use partly relieves the Genital and Sexual Symptoms of Genitourinary Syndrome of Menopause (GSM) in Women
  • Nicolas Mendoza Ladron De Guevara (ES)
    P.395 Clinical Relevance of Ashwagandha Extract on Bone Turnover Biomarkers in Postmenopausal Women: A 24-Week Randomized Controlled Trial
  • Nicolas Mendoza Ladron De Guevara (ES)
    P.396 Clinical relevance of ashwagandha extract on menopause-specific quality of life: a 24-week randomized controlled trial in postmenopausal women
  • Rossella Nappi (IT)
    P.397 Efficacy of elinzanetant for the treatment of vasomotor symptoms across subgroups: a pooled analysis of the Phase III OASIS-1 and -2 trials
  • Claudio Lera Orsatti (BR)
    P.398 Resistance Exercise Promotes Mobilization of CD8+ Cells Expressing TLR3 and IL-1β into the Circulation in Postmenopausal Women
  • Jose Maria Soares-Jr (BR)
    P.399 Fractional Microablative Radiofrequency for Genitourinary Syndrome of Menopause: A Pilot Study Comparing Clinical and Histological Outcomes in Postmenopausal Women and Gynecological Cancer Survivors
  • Wallace Viana e Silva (BR)
    P.400 Self-Care Capacity as a Determinant of Psychological Menopausal Symptoms in Midlife Women
  • Arturo Arellano Eguiluz (MX)
    P.400B Effect of menopausal hormone therapy on sexual function among Mexican women: A cross-sectional study
  • Santiago Palacios Gil-Antuñano (ES)
    P.401 Effectiveness of a Trigonella-based food supplement for the improvement of sexual desire and arousal in pre and postmenopausal women. The LIBIDOBS real-life study.
  • Jose Maria Soares-Jr (BR)
    P.402 Clitoral Androgen Therapy: A Targeted Breakthrough for Improving Orgasmic Function and Relieving Dyspareunia in Postmenopausal Women
  • Ana Valadares (BR)
    P.403 A Survey of Brazilian Gynecologists' Prescribing Practices and Attitudes Toward Testosterone Use in Women
  • Luciana Bergamaschi Santacruz (ES)
    P.404 Menopausal hormone therapy effects on biometrics: 6 months of orally daily treatment with e2 img and p4 ioomg.
  • Raluca Mogos (RO)
    P.405 Bioidentical Hormone Therapy: Evidence-Based Insights for Clinical Practice
  • Luís Carlos Sakamoto (BR)
    P.406 Prevalence of Breast Cancer Subtypes and the Incidence of Obesity
  • Panagiotis Anagnostis (GR)
    P.407 Association between vasomotor symptoms and risk of dementia in peri- and postmenopausal women: a systematic review and meta-analysis
  • Elena Pavicic (CH)
    P.408 The influence of Black Cohosh on hippocampal and hypothalamic gene expression profiles in ovariectomized rats and its potential to treat menopausal decrease in smell discrimination
  • Muniss Shukurova (UZ)
    P.409 Ferulen as a Phytotherapeutic Selective Estrogen Modulator in Surgical Menopause: Clinical and Metabolic Outcomes
  • Amrita Halmos (HU)
    P.410 Endometrial protection during perimenopause and menopausal hormone therapy
  • Debora Krakauer (BR)
    P.411 Domestic Violence, Psychosomatic and Sexual Health Consequences in Climacteric Women
  • Vazira Abdusamatova (UZ)
    P.412 Analysis of the Role of BRCA1 and BRCA2 Genes as Predictors of Ovarian Cancer. Prevalence of Ovarian Cancer in the Republic of Uzbekistan.
  • Alexandra Axenova (RU)
    P.413 In Situ Ovarian Protection: Emerging Pharmacological and Biophysical Strategies Against Radiation-Induced Gonadotoxicity and Spaceflight Exposure
  • Kátia Carvalho (BR)
    P.414 Differential microRNA profile in T47D cells treated with melatonin and estradiol: Evidence of a modulatory effect of melatonin on hormone-related pathways in hormone-dependent invasive ductal carcinoma cells.
  • Alina Fudulu (RO)
    P.415 ZNF627 expression and dynamic correlation with LINC01718 enable improved stratification of cervical precancerous lesions
  • Daria Koleva (BG)
    P.416 Granulosa Cell Tumor in a Young Woman with Peutz–Jeghers Syndrome: A Case Report and Review of Gynecological Implications
  • Tatielly Teles de Miranda (BR)
    P.417 miRNAs regulating Growth Factors expression profile in Uterine Smooth Muscle Tumors
  • Mata Zakaraeva (RU)
    P.418 Malignant Mixed Müllerian Tumor in a 13-year Old Patient: a Case Report
  • Tsotne Dadiani (GE)
    P.419 Endometriosis-Associated Malignant Transformation Arising in a Laparotomy Scar: A Rare Case Report and Literature Review
  • Bîcă Ovidiu Daniel (RO)
    P.420 The Estrobolome as a Molecular Axis in Pediatric Biogenomic Surgery: Integrating Endocrine Recovery, Microbiome, and Precision Ovarian Surgery
  • Natalie Gierat (US)
    P.421 Evaluation of Anti-Cancer Activity of Copper-Tolfenamic Acid Against Ovarian Cancer Cells
  • Alexandra Axenova (RU)
    P.422 Fertility Preservation in Female Cancer Survivors: Current Clinical Outcomes, Hormonal Safety, and Decision-Making Strategies Across Tumor Types
  • Jaya Chaturvedi (IN)
    P.423 Counselling to screening: honing an institutional cervical cancer screening program
  • Rajlaxmi Mundhra (IN)
    P.424 Diagnostic accuracy of CBC inflammatory parameters in differentiating benign and malignant adnexal masses
  • Elena Andreeva (RU)
    P.24b Diagnostic value of steroid profile in secondary amenorrhea
  • Gvantsa Apriamashvili (GE)
    P.425 From Knowledge to Action: HPV Vaccine Awareness and Acceptance in Georgia
  • Victoria Bugai (MD)
    P.426 Awareness and Acceptance of HPV Vaccination Among Parents in the Republic of Moldova
  • Victoria Bugai (MD)
    P.427 Assessment of medical students’ knowledge regarding HPV
  • Raynara Gomes (BR)
    P.428 Impact of HPV vaccination in brazil: a decade of public health impacts
  • Kseniia Kondrashkina (RU)
    P.429 HPV Persistence, Cervicovaginal Microbiome, and Local Immunity: Toward a Personalized Strategy for HPV-Associated Disease Prevention
  • Haleema Sadia (PK)
    P.430 Awareness, Attitudes, and Acceptance of the HPV Vaccine Among Female Healthcare Students in Pakistan
  • Raynara Uchôa Gomes (BR)
    P.431 Vaccination Against HPV in Brazil ( January to December 2024 )
  • Boram Yu (KR)
    P.432 Diagnostic methods of endometrial pathologies in breast cancer patients taking tamoxifen: a retrospective study
  • Milena Brkic (BA)
    P.433 Malignant Phyllodes Tumor Mimicking Recurrent Fibroadenoma: A Case Report
  • Kholmirza Rashidov (UZ)
    P.434 Features of breast cancer carcinogenesis: clinicopathological analysis and risk factor assessment
  • Rafał Watrowski (DE)
    P.435 Beyond the Ideal: Puerperal abscess sequelae in Salviati’s "Charity" - a medical, iconographic, and theological interpretation
  • Slađana Pejaković (RS)
    P.436 Breastfeeding Course through the lens of maternal hypothyroidism
  • Dragan Stajić (RS)
    P.437 The Breastfeeding Self-Efficacy Scale–Short Form (BSES-SF): Psychometric Assessment of the Serbian version
  • Yuejiao Wang (CN)
    P.438 Serum microRNA-181a Expression Level in Breast Cancer Patients and Its Correlation with Circulating PGRMC1
  • Zeynep Karakus (TR)
    P.439 Bibliometric Analysis of Breast Cancer Studies in Nursing in the Last Decade (2016-2025): A Descriptive Study
  • Luiz Fernando Dardis (BR)
    P.440 Self-care agency and sexual function in the postoperative period of women with breast cancer
  • Edi Muhaxhiri (RS)
    P.441 Laparoscopic removal of a large pelvic hydatid cyst: A case report.
  • Silvia Agop (MD)
    P.442 Endometriosis in Cesarean Section Scar: From Clinical Suspicion to Definitive Diagnosis
  • Manana Gegechkori (GE)
    P.443 Unicornuate Uterus with Rudimentary Horn - Prospective Gynecological and Obstetric Complications - A Review of Clinical Cases
  • Sergio Henrique Bastos Damous (BR)
    P.444 Surgical outcomes of patients with different degrees of endometriosis – Experience of a prospective cohort
  • Daniela Nakuci (AL)
    P.445 Pathological correlation of deep infiltrating endometriosis and adenomyosis in a young woman: a case-based observation
  • Mayara Souza Alves (BR)
    P.446 Development and application of a questionnaire to assess the quality of life of patients with different degrees of endometriosis after surgical treatment
  • Ilaria Catrambone (IT)
    P.447 High uterosacral ligament suspension by transvaginal natural orifice transluminal endoscopic surgery (vNOTES): a pilot study on surgical outcomes
  • Nina Davidova (GE)
    P.448 Effectiveness of Vaginal Pessaries in the Conservative Management of Pelvic Organs Prolapse
  • Valeriia Seregina (RU)
    P.449 Surgical energies in reproductive medicine in women today: fundamental and clinical aspects
  • Sho Takeshita (JP)
    P.450 Usefulness of the Double Bipolar Technique with the da Vinci SP System for Total Hysterectomy in Cases of Large Uterine Myomas
  • Sho Takeshita (JP)
    P.451 Comparison of Single-Mesh Sacrocolpopexy Using da Vinci Xi and SP Systems: A Single-Surgeon Retrospective Study Evaluating Surgical Outcomes and Learning Curve
  • Ian Vasicka (US)
    P.452 An update on the genetic etiology of pelvic organ prolapse (POP): a recent review of the literature over the past five years.
  • Fakhriddin Miraliev (UZ)
    P.453 Retrospective Analysis of the Causes of Recurrence After Surgical Treatment of Pelvic Organ Prolapse
  • Lilia Obosyan (RU)
    P.454 Advanced Laser-Assisted Diagnosis and Treatment of Intrauterine Adhesions in Women with Complex Obstetric and Gynecologic Histories
  • Cláudia Oliveira (PT)
    P.455 Severe vaginal stenosis - Is vaginohysteroscopy a feasible approach for evaluating suspected cervical pathology?
  • Ekaterina Tugay (RU)
    P.456 Hysterosalpingography in the Infertility Work-Up: Indications, Tolerability, Diagnostic Yield, and Short-Term Prognosis in a Single-Center Cohort
  • Niko Heiss (FR)
    P.457 Ultrasound Assessment of the Efficacy of Erbium:YAG Laser Therapy in the Treatment of Stress Urinary Incontinence
  • Maria Luisa Mendes (PT)
    P.458 Incidental Diagnosis of an Atypical Cervical Cyst in a Woman with Late Menopause: A Case Report
  • Fatma Zaiter (TN)
    P.459 Performance of the O-RADS Ultrasound Classification in Risk Stratification of Adnexal Masses: A Histopathological Correlation Study
  • Dorina Adelina Minciuna (RO)
    P.460 AnnoCerv Dataset: Advancing AI-Based Colposcopy for Cervical Cancer Detection
  • Martin Vladimirov (BG)
    P.461 Correlation Between Colposcopic Findings and HPV Genotypes in Multifocal Precancerous Lesions of the Female Genital Tract
  • FATJON BALLA (AL)
    P.462 Successful management of infertility in a young woman with bilateral tubectomy for chronic salpingitis and ovarian cyst: the role of laparoscopic surgery in ovarian preservation
  • Shayman Gadimova (AZ)
    P.463 Effectiveness of Laparoscopy in the Surgical Management of Ovarian Dermoid Cysts
  • Nutan Agarwal (IN)
    P.464 Measurement of amniotic fluid index (AFI) and establishing its normal values in level 1(11-13+6 weeks) ultrasound by innovative technique and correlation of AFI to risk of developing fetal malformation.

Thursday 05 March

ISGE 1 Therapeutic Forum 08:45-09:45
ADD FAVOURITE

Medical strategies to achieve ovulation induction

chairperson: Eileen Manalo
  • Basil Tarlatzis (GR)
    Medical strategies to achieve ovulation induction
ISGE 2 Debate 08:45-09:45
ADD FAVOURITE

Is decreased sexual function a disease?

chairperson: Alessandra Graziottin
  • Salvatore Caruso (IT)
    Is decreased sexual function a disease?
  • Johannes Bitzer (CH)
    Is decreased sexual function a disease?
ISGE 3 Meet the Expert 08:45-09:45
ADD FAVOURITE

Breast cancer

chairperson: Piero Sismondi
  • Alfred Mueck (DE)
    Can screening reduce the breast cancer risk induced by HRT?
  • Anne Gompel (FR)
    Endocrine challenges of breast cancer survivors
ISGE 4 Debate 08:45-09:45
ADD FAVOURITE

Gender dysphoria: current ethical and medical challenges

chairperson: Maria Cristina Meriggiola
  • Kai Haldre (EE)
    Gender dysphoria: current ethical and medical challenges
  • Alessandra Fisher (IT)
    Gender dysphoria: current ethical and medical challenges
ISGE 5 Oral Presentation 08:45-09:45
ADD FAVOURITE

Premature ovarian insufficiency

chairpersons: Alexandra Axenova , Vincenzo Scotto Di Palumbo
  • Andreia Lima Martins (PT)
    Obstetric outcomes in women with primary ovarian insufficiency following oocyte donation - a retrospective study
  • Vidushi Kulshrestha (IN)
    Trabecular bone score (TBS) in women with primary ovarian insufficiency (POI) and its correlation with bone mineral density.
  • Maria Yarmolinskaya (RU)
    A New Method for the Treatment of Premature Ovarian Insufficiency Based on the Effect of Omaveloxolone (RTA 408) on the Mitochondrial Function of Granulosa Cells
  • Svetlana Yureneva (RU)
    Premature ovarian failure and comorbid mental disorders
  • Yulia Bandrivska (UA)
    Environmental Phosphates and Female Rats Reproductive Health
ISGE 6 Oral Presentation 08:45-09:45
ADD FAVOURITE

Uterine fibroids and adenomyosis

chairpersons: Giovanna Maria Salerno , Catarina G. Costa
  • Andre Luiz Malavasi Longo de Oliveira (BR)
    Gestrinone Subdermal Bioabsorbable Implant for Treatment of Endometriosis-Associated Pelvic Pain: A Safety Randomized Clinical Trial
  • Sara Monteduro (IT)
    Quality of life and sexual function in women with uterine fibromatosis treated with Relugolix Combination Therapy
  • Giulia Monaco (IT)
    Association between ESHRE/ESGE congenital uterine malformations and endometriosis/adenomyosis: identification of the malformations most associated and detection of the #ENZIAN compartments most frequently involved
  • Mariami Kaviladze (RU)
    Efficacy and Safety of Indole-3-carbinol (I3C) in Treatment of Uterine Fibroids: a prospective longitudinal multicenter study
  • Pilar Lafuente González (ES)
    Clinical Applicability of Linzagolix Therapeutic Flexibility Illustrated Through Clinical Cases
  • Mandy Mangler (DE)
    Rapid Improvement in Heavy Menstrual Bleeding and Anaemia with Linzagolix in Women with Uterine Fibroids: Post-hoc Analysis of the PRIMROSE 1 and 2 Trials.
  • Kyriakos Kakoullis (CY)
    A Novel Low-Energy, Multiple Overlapping Transvaginal Ultrasound –Guided Microwave Fibroid Ablation (TVUS-MWFA) Technique for Symptomatic Uterine Fibroids (UF) - A Single-Centre Case Series
  • Natig Maharramov (AZ)
    Pregnancy Outcomes Following Laparoscopic Myomectomy: The Role of Surgical Technique in Fertility Preservation
ISGE 7 Oral Presentation 08:45-09:45
ADD FAVOURITE

Endometrial deficiency and therapy

chairpersons: Marija Gjorgoska , Andrea Giannini 
  • Mariami Andguladze (GE)
    Adrenal–Ovarian Axis Crosstalk in Women with DHEA Deficiency and Early Menopause: Mechanistic and Therapeutic Perspectives
  • Edmund C Baracat (BR)
    Pharmacokinetics of subcutaneous hormonal bioabsorbable implants of estradiol and testosterone in postmenopausal women
  • Christian Battipaglia (IT)
    Endocrine and metabolic changes during long-term oral Dehydroepiandrosterone supplementation in postmenopausal women
  • George Tevdorashvili (GE)
    Combined DHEA and Menopausal Hormone Therapy in Early Postmenopausal Women: Effects on Hormonal and Clinical Parameters
  • Marina Martinelli Sonnenfeld (BR)
    Use of Testosterone Implants in the Treatment of Androgen Deficiency in Women: A Systematic Review
  • Andre Malavasi (BR)
    Thromboelastometry (ROTEM) Assessing Coagulability in Postmenopausal Women Using Subcutaneous Bioabsorbable Estradiol and Testosterone Implants
ISGE 8 Scientific Society Symposium 08:45-09:45
ADD FAVOURITE

Obesity and Endocrine Disorders of the Women

Organized by Hellenic Society of Gynecological Endocrinology
chairpersons: George Adonakis , Efthymios Deligeoroglou
  • Vasileios Karountzos (GR)
    Obesity and Menstrual Disorders: Diagnostic and Therapeutic Challenges
  • Konstantinos Dafopoulos (GR)
    Obesity Management in Anovulatory PCOS Patients
  • Ioannis Boutas (GR)
    The role of Diet and Body Weight, in Breast Cancer Survivors
  • Evangelos Makrakis (GR)
    IVF in Obese Women: Effects and Challenges
ISGE 9 Scientific Society Symposium 08:45-09:45
ADD FAVOURITE

Relevant aspects in menopause and andropause

Organized by Asociación Argentina de Menopausia y Andropausia (AAMA)
chairpersons: Mónica Nañez , Nestor Siseles
  • Élida Rodríguez (AR)
    Platelet-rich plasma in Genitourinary Syndrome: new ally?
  • Mónica Ñañez (AR)
    High Intensity Focused ultrasound in GSM: efficacy and safety
  • Alejandra Belardo (AR)
    Sleep disorders in menopause and andropause a challenge of daily practice
  • Alejandra Shüle (AR)
    Discussion
  • Mariela Fuentes Costilla (AR)
    Discussion
ISGE 10 Scientific Society Symposium 08:45-09:45
ADD FAVOURITE

Dose dependent gonadal steroid effects on different tissues.

Organized by Serbian Society for Endocrinology of Gender (SSEG)
chairpersons: Svetlana Spremovic Radjenov , Svetlana Vujovic
  • Svetlana Vujovic (RS)
    Stressors and Premature Ovarian Insufficiency
  • Svetlana Spremovic Radjenovic (RS)
    Endometriosis: A Therapeutic Challenge
  • Milina Tancic Gajic (RS)
    Polycystic Ovary Syndrome and Hyperandrogenism: A Diagnostic Reappraisal
  • Marija Miletic (RS)
    Sex Hormones and Skeletal Muscle Modifications in Women
ISGE 1 Symposium 09:50-11:20
ADD FAVOURITE

Brain Aging and woman’s health

chairpersons: Roberta Diaz Brinton , Walter Rocca 
  • Claudio Soares (CA)
    Menopause, mood and depression
  • Walter Rocca (US)
    Premature or early menopause and risk of neurodegenerative diseases
  • Herman Depypere (BE)
    Is there a link between MHT and dementia?
  • Pablo Carpintero (AR)
    Brain Aging in Women: Neuroendocrine Mechanisms, Modifiers, and Windows for Intervention
ISGE 2 Symposium 09:50-11:20
ADD FAVOURITE

VA/GSM and lichen sclerosus: clinical best practice and evidence for new therapies

Sponsored by Stratpharma
chairpersons: Eduardo Serrano , Andrea Genazzani
  • ()
    Welcome and introduction
  • Andrea Genazzani (IT)
    Distinguishing VA/GSM and Lichen Sclerosus in clinical practice: diagnosis and treatment considerations
  • Robyn B Faye (US)
    Clinical best practice for Lichen Sclerosus: managing disease, symptoms, and patient quality of life
  • Philip Hall (AU)
    Patient-centric outcomes in Lichen Sclerosus (LS) and GSM: insights from clinical evidence
ISGE 3 Symposium 09:50-11:20
ADD FAVOURITE

Bone health after menopause: prevention, diagnosis and long-term care

Sponsored by Gedeon Richter
chairpersons: Salvatore Minisola , Mark Brincat
  • Santiago Palacios (ES)
    Diagnosis of osteoporosis and fracture risk assessment
  • Petra Stute (CH)
    Treating osteoporosis , optimising bone mass, and reducing fracture risk
  • Lothar Seefried (DE)
    Long-term management and secondary prevention
ISGE 4 Symposium 09:50-11:20
ADD FAVOURITE

Hormones and cancer

chairpersons: Alfred Mueck , Paolo Scollo
  • Frederick Naftolin (US)
    P80, a novel protein in cancer biology, recognition and management
  • Valentina Elisabetta Bounous (IT)
    Menopause after breast cancer
  • Christel Pequeux (BE)
    Specific transcriptomic programs induced by progesterone and bazedoxifene to prevent estradiol-driven proliferation in the human endometrium
  • Irene Lambrinoudaki (GR)
    Bone health after breast cancer
ISGE 5 Symposium 09:50-11:20
ADD FAVOURITE

Come il ginecologo può cambiare la traiettoria di salute con semaglutide dall’età fertile alla menopausa

Sponsored by Novo Nordisk
chairperson: Rossella Nappi
  • Rossella Nappi (IT)
    Eccesso di peso e salute della donna: una priorità clinica per il ginecologo
  • Luca Busetto (IT)
    Semaglutide 2,4 mg: benefici ponderali e cardiometabolici
  • Silvia Maffei (IT)
    Come integrare semaglutide nel percorso terapeutico
  • Luca Busetto (IT)
    Presa in carico e aderenza terapeutica: tips di pratica clinica
  • Silvia Maffei (IT)
    Presa in carico e aderenza terapeutica: tips di pratica clinica
  • Rossella Nappi (IT)
    Chiusura e take home messages
ISGE 6 Scientific Society Symposium 09:50-11:20
ADD FAVOURITE

Reproductive medicine today. Endometriosis and artificial intelligence.

Organized by Russian Society of Reproductive Medicine and Surgery (RSRMS)
chairperson: Leila Adamyan
  • Leila Adamyan (RU)
    Reproductive medicine today, the role of AI. Endometriosis: own experimental and clinical data
  • Vitaly Bezhenar (RU)
    Chronic pelvic pain in patients with endometriosis: a challenge to solve
  • Maria Yarmolinskaya (RU)
    Modern aspects of endometriosis: surgery or medicine
  • Victoria Kasyan (RU)
    The era of safe estrogens
ISGE 7 Oral Presentation 09:50-11:20
ADD FAVOURITE

Contraception

chairpersons: Aspasia Manta , Carlo Bastianelli
  • Kristina Gemzell-Danielsson (SE)
    The ESCONEC Project: Rethinking the Estrogen Component in Combined Hormonal Contraception
  • Frida Gyllenberg (FI)
    Effects of hormonal contraception on mood symptoms – A randomized, double-blind, longitudinal study
  • Kim Peters (DE)
    Health-related quality of life outcomes among women using estetrol/drospirenone for contraception: findings from the CARE4HER real-world observational study
  • Lucie Raskin (BE)
    Assessment of the risk of venous thromboembolism of combined hormonal contraceptives or progestin-only contraceptives in women over 18 in comparison with non-users or any other contraceptive
  • Sofia Tornvall (SE)
    Combined oral contraceptives suppress classical and 11-oxygenated androgens in healthy women: insights from a placebo-controlled trial
  • Lali Pkhaladze (GE)
    The Effect of E4/DRSP on Menstrual Symptoms and Health-related Quality of Life in Adolescents
  • Norman Goldstuck (ZA)
    Is modern hormonal contraception a form of hormone replacement therapy for nulliparous women?
  • Jonathan Douxfils (BE)
    Advancing Combined Hormonal Contraception: The Scientific and Clinical Rationale for Natural Estrogens
ISGE 8 Oral Presentation 09:50-11:20
ADD FAVOURITE

Non-hormonal treatments for climacteric women

chairpersons: Rossana Tripodi , Camille Flas
  • Rebecca C. Thurston (US)
    OPTION-VMS: First real-world fezolinetant effectiveness and safety data, including objective sleep data, in a phase 4 longitudinal, observational study of non-hormonal treatments for bothersome menopause-associated vasomotor symptoms
  • Paula Briggs (GB)
    Trial in Progress: HIGHLIGHT 1 - A randomized, placebo-controlled, double-blind, phase 3 clinical study to investigate the efficacy and safety of fezolinetant for treatment of moderate to severe vasomotor symptoms (hot flashes) in women with stage 0 to 3 hormone receptor-positive breast cancer who are receiving adjuvant endocrine therapy
  • Paula Briggs (GB)
    Efficacy of elinzanetant 120 mg across different populations of women from four phase 3 OASIS studies
  • Elif Inan Eroglu (DE)
    AI-Driven Analysis of Exit Interviews from OASIS-1 and -2 Elinzanetant Clinical Trials: Novel Insights Beyond Traditional Endpoints
  • Marcelo Graziano Custodio (CH)
    Abstract for REasonS for DiscONtinuation of Non-HormonAl Therapy in MenopausE (RESONATE) Study
  • Fiona Baker (US)
    Consistency in effect of elinzanetant on wakefulness after sleep onset across subjective and objective measures: post hoc analysis of the Phase II NIRVANA pilot study
  • Rebecca Thurston (US)
    Rapid sustained effects of elinzanetant for the treatment of VMS and sleep disturbances in postmenopausal women
  • Senka Djordjevic (CH)
    Perceived effectiveness of non-hormonal treatment for vasomotor symptoms associated with menopause from the perspective of postmenopausal women and healthcare providers
  • Zoe Schaedel (GB)
    Efficacy and safety of daridorexant in women with insomnia disorder during menopausal transition: a subgroup analysis
  • Paola Villa (IT)
    Long-term effectiveness of ospemifene in treatment of moderate to severe vulvo-vaginal atrophy in women with and without history of breast cancer: the PatiEnt satisfactiON studY (PEONY) study.
  • Zoe Schaedel (GB)
    Efficacy and Safety of Daridorexant in Women with Hypothyroidism and Insomnia Disorder: A Subgroup Analysis
ISGE 9 Scientific Society Symposium 09:50-11:20
ADD FAVOURITE

Il modello bio-psico-sociale in sessuologia: dalla fisiopatologia alla clinica.

Organized by Federazione Italiana di Sessuologia Scientifica (FISS)
chairpersons: Salvatore Caruso , Adele Fabrizi
  • Vieri Boncinelli (IT)
    Rivisitazione della Risposta Sessuale Femminile
  • Roberta Rossi (IT)
    Oncosessuologia, interventi per la salute sessuale
  • Roberta Giommi (IT)
    La depressione femminile e la crisi del corpo e della coppia. Come fornire strategie
  • Anna Gualerzi (IT)
    Impatto delle patologie mediche chirurgiche maschile sulla sessualità di coppia
ISGE 10 Scientific Society Symposium 09:50-11:20
ADD FAVOURITE

Safety Issues in Contraception

Organized by International Academy of Human Reproduction - IAHR
chairpersons: Joseph Schenker , Giuseppe Benagiano
  • Jonathan Douxfils (BE)
    Lower risk of venous thromboembolism with body-identical estrogens in contraception: evidence from multiple levels
  • Anne Gompel (FR)
    Contraception and breast
  • Martin Birkhaeuser (CH)
    Bone safety - the neglected risk in Contraception
ISGE 2 Symposium 11:50-13:20
ADD FAVOURITE

Managing menopause: fezolinetant for the targeted treatment of vasomotor symptoms

Sponsored by Astellas
chairperson: Tim Hillard
  • Tim Hillard (GB)
    Welcome and introductions
  • Petra Stute (CH)
    Understanding vasomotor symptoms: their impact and mechanism
  • Rossella Nappi (IT)
    Exploring fezolinetant: from clinical trials to clinical practice
  • ()
    Q&A
ISGE 3 Symposium 11:50-13:20
ADD FAVOURITE

Frontiers of medically-assisted procreation

chairpersons: Basil Tarlatzis , Amala Nazareth
  • Filippo Ubaldi (IT)
    The DuoStim concept
  • Valeria Donno (IT)
    Progesterone-primed ovarian stimulation
  • Nicola Pluchino (CH)
    Effect of IVF on pain and quality of life in women with endometriosis
  • Inmaculada Moreno (ES)
    The impact of the microbiome in reproductive health
ISGE 4 Symposium 11:50-13:20
ADD FAVOURITE

Difficult contraceptive care

chairpersons: Nilson Roberto De Melo , Martin Birkhaeuser
  • Gabriele Susanne Merki (CH)
    Contraception in women with multiple sclerosis
  • Giovanni Grandi (IT)
    Contraception in women at increased thromboembolic risk
  • Nestor Siseles (AR)
    Contraception and comorbidities in the menopausal transition
  • David Vasquez Awad (CO)
    Contraception and cancer
ISGE 5 Symposium 11:50-13:20
ADD FAVOURITE

L’obesità e le ricadute sulla biologia femminile: come gestire e che fare?

Organized by AIGE
chairperson: Costantino Di Carlo
  • Alessandro Genazzani (IT)
    Il tessuto adiposo come organo endocrino nell’ovaio policistico (PCOS) e nella menopausa
  • Silvia Maffei (IT)
    Obesità, rischio cardiovascolare e oncologico
  • Giovanni Ceccarini (IT)
    L’approccio all’obesità: le scelte di terapia
ISGE 6 Oral Presentation 11:50-13:20
ADD FAVOURITE

PCOS 2

chairpersons: Ritu Kushwah , Francis Zegher
  • Mariami Andguladze (GE)
    Comparative Effects of Combined Inositols and Alpha-lipoic Acid (ALA) on Metabolic, Hormonal and Clinical Outcomes in Obese Hyperinsulinemic Women with Polycystic Ovary Syndrome (PCOS): The Impact of Family History of Diabetes
  • Aspasia Manta (GB)
    The association between body image and emotional well-being in polycystic ovary syndrome: a mixed-methods study
  • Olga Stercel (HU)
    The role of preconception androgen levels and mode of conception in the obstetric outcomes of women with polycystic ovary syndrome O. Stercel, Sz. Csehely, R. Lampé, A. Jakab, T. Deli, M. Orosz
  • Tetiana Tutchenko (UA)
    Anti-Müllerian Hormone (AMH) as a Diagnostic and Management Biomarker for Polycystic Ovary Syndrome (PCOS): Towards Establishing National Cut-offs
  • Ekaterina Orekhova (RU)
    Nutritional supplementation in patients with functional hypothalamic amenorrhea and Polycystic ovary syndrome: opportunities and prospects
  • Hexia Xia (CN)
    Exploring the role of kisspeptin in polycystic ovary syndrome and its associated pregnancy complications
ISGE 7 Oral Presentation 11:50-13:20
ADD FAVOURITE

Surgery

chairpersons: Stefano Cosma , Amerigo Ferrari
  • Sanpon Diawtipsukon (TH)
    The effect of absorbable adhesion barrier gel on reducing post-surgical adhesions in women undergoing cesarean section: a randomized controlled pilot study
  • Catarina G Costa (PT)
    Transvaginal Radiofrequency Ablation of Uterine Fibroids – Experience in a Portuguese Tertiary Hospital
  • Anna Cicigoi (IT)
    vNOTES vs Conventional Laparoscopy in the Surgical Management of adnexal pathologies: a retrospective comparison
  • Amerigo Ferrari (IT)
    Robot-assisted, laparoscopic and transvaginal surgery for pelvic organ prolapse: a comparative retrospective single-center study
  • Maria Macarena Castiglione (CL)
    Müllerian Malformation as a Cause of Secondary Dysmenorrhea: A Case Report
  • Joana Galvao (PT)
    Emergency hysteroscopy – Another Tool for Acute Gynecological Bleeding due to Intrauterine Pathology
  • Laura Pivazyan (RU)
    Antifibrotic treatment of endometriosis: experimental data
  • Ana Carolina Mateus (PT)
    Uterine artery embolization: 17 years of experience from a tertiary center
  • Azizbek Valijonov (UZ)
    Surgical Treatment and the Advantages of Laparoscopy in Adenomyosis.
  • Miguel Caceres (PA)
    Clinical Outcomes of Myomectomy Using the Hugo Robotic-Assisted Surgery System: A Multicenter Post-Market Study
ISGE 8 Scientific Society Symposium 11:50-13:20
ADD FAVOURITE

Role of gonadal steroids in musculoskeletal health and aging.

Organized by European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (esceo)
chairpersons: Tommaso Simoncini , Jean-Yves Reginster
  • Francesco Landi (IT)
    Role of gonadal steroids in the pathogenesis and management of sarcopenia
  • Jean-Yves Reginster (CH)
    Role of gonadal steroids in the management of osteoporosis
  • Alberto Migliore (IT)
    Role of gonadal steroids in the pathogenesis and management of osteoarthritis
ISGE 9 Scientific Society Symposium 11:50-13:20
ADD FAVOURITE

Out- of- the- ordinary topics in Gynecological endocrinology

Organized by Sociedad Argentina de Endocrinología Ginecológica y Reproductiva (SAEGRE)
chairperson: Fabian Gomez Giglio
  • Sandra Demayo (AR)
    Unveiling the Role of chronic stress and inflammation in aging and degenerative diseases
  • Blanca Campostrini (AR)
    The hidden connection between microbiota -hormone-cancer during the climacteric. What’s new?
  • Soledad Belingeri (AR)
    Bone-Muscle Crosstalk in Health and Disease
  • Yanina Azas (AR)
    Environment and Woman´s Health: A complex and multifaceted Relationship
  • Mariana Jarlip (AR)
    Discussion
  • Micaela Rodriguez Turi (AR)
    Discussion
  • Solanage Cieri (AR)
    Discussion
ISGE 10 Scientific Society Symposium 11:50-13:20
ADD FAVOURITE

POI: Bridging Diagnosis, Impact, and Therapy

Organized by Sociedad Chilena de Climaterio (SOCHICLIM)
chairperson: Margot Acuña San Martin
  • Gina Acosta (CL)
    Definition, Prevalence, and Risk Factors
  • Carla Reyes (CL)
    Diagnosis
  • Hugo Salinas (CL)
    Fertility and pregnancy
  • Victor Valverde (CL)
    Cardiometabolic and musculoskeletal health
  • Soledad Vallejo (CL)
    Treatment Options
ISGE 1 Lunch Symposium 13:40-15:10
ADD FAVOURITE

Neurokinin targeted therapy: a new approach to treating menopause symptoms

Sponsored by Bayer
chairpersons: Tommaso Simoncini , Antonio Cano
  • Tommaso Simoncini (IT)
    Welcome and introduction
  • Victor Navarro (US)
    Dialogue: KNDy neurons and the science behind menopause
  • Rossella Nappi (IT)
    Dialogue: KNDy neurons and the science behind menopause
  • Donal Brennan (IE)
    Managing menopausal symptoms in breast cancer survivors
  • Antonio Cano (ES)
    Summary and close
ISGE 5 ISGE Scholarship course 15:10-17:45
ADD FAVOURITE

Course 2

  • Nilson De Melo (BR)
    The history of hormonal contraception
  • Xiangyan Ruan (CN)
    Management of infertility in PCOS
  • Peter Chedraui (EC)
    Diagnosis and management of hypertensive disorders of pregnancy
ISGE 1 Symposium 15:40-17:10
ADD FAVOURITE

Menopause and the heart

chairpersons: Nestor Siseles , Cuauhtémoc Celis Gonzáles
  • Nicolas Mendoza (ES)
    Exercise and health after menopause
  • Peter Chedraui (EC)
    Metabolic changes and CVD across the menopausal transition
  • Peter Collins (GB)
    Microvascular angina and menopause
  • John Stevenson (GB)
    HRT in women with established coronary disease
ISGE 2 Symposium 15:40-17:10
ADD FAVOURITE

The herbal drug Vitex agnus-castus: old friend, internal bliss and promising future

Sponsored by Bionorica
chairperson: Andrea Genazzani
  • Jürg Gertsch (CH)
    The herbal drug Vitex agnus-castus: internal bliss beyond dopamine
  • Christoph Abels (DE)
    The herbal drug Vitex agnus-castus: pharmacokinetics, safety, and fingerprinting in healthy participants – a phase I clinical trial
  • Petra Stute (CH)
    The herbal drug Vitex agnus-castus: clinical data for a promising future
ISGE 3 Symposium 15:40-17:10
ADD FAVOURITE

Bridging science and clinical practice in endometriosis and uterine fibroids: the role of linzagolix▼

Sponsored by Theramex
chairperson: Felice Petraglia
  • Felice Petraglia (IT)
    Welcome & Introductions
  • Jacques Donnez (BE)
    Endometriosis: pathophysiology and the evolving landscape of medical treatment
  • Mariona Rius (ES)
    Endometriosis in practice: real-world patient cases with linzagolix
  • Jacques Donnez (BE)
    Uterine fibroids: pathophysiology and the evolving landscape of medical treatment
  • Mandy Mangler (DE)
    Uterine fibroids in practice: real-world patient cases with linzagolix
  • Massimo Stomati (IT)
    Uterine fibroids in practice: real-world patient cases with linzagolix
  • Felice Petraglia (IT)
    Panel discussion: Q&A from the audience
ISGE 4 Symposium 15:40-17:10
ADD FAVOURITE

Neuroendocrinology revisited

chairpersons: Angelica Lindén Hirschberg , Andrea Fabbri
  • Blazej Meczekalski (PL)
    Kisspeptin and Neurokinin B - potential therapeutic roles role in gynecological endocrinology
  • Rossella Nappi (IT)
    Neuroendocrine substrates of sexuality in women
  • Regine Sitruk-Ware (US)
    Progesterone, progestins and the brain
  • Duru Shah (IN)
    AMH, the Ovary, Placenta, and the Brain: do they have a Gossip Session?
ISGE 6 Scientific Society Symposium 15:40-17:10
ADD FAVOURITE

Improving reproductive health: Reproductive research in progress in Hungary

Organized by Hungarian Society of Gynecological Endocrinology
chairpersons: Attila Jakab , Várbíró Szabolcs
  • Kalman Kovacs (HU)
    Microplastics as emerging endocrine disruptors in female reproductive health
  • Szilvia Csehely (HU)
    Prevalence of POI etiologies and impact of time to diagnosis on bone health
  • Katalin Nas (HU)
    Improving the effectiveness of ovarian stimulation by influencing carbohydrate metabolism
  • István Péterfi (HU)
    The importance of screening and management of pregnancy related iron deficiency: results of anemia screening program in a population of 3000 pregnant women
  • Tamás Deli (HU)
    Optimizing pharmacologic and mechanical cervical ripening and labor induction: a retrospective study
  • Balazs Erdodi (HU)
    How COVID-19 pandemic affected the management of adnexal masses
ISGE 8 Oral Presentation 15:40-17:10
ADD FAVOURITE

Medically assisted procreation

chairpersons: Roberto Marci , Ekaterina Orekhova
  • Marcelo Montenegro (BR)
    Increased leptin levels in follicular fluid from obese women affect oocyte and embryo quality during in vitro fertilization treatments
  • Pietro Molinaro (IT)
    Impact of hormone replacement therapy on serum thyroid-stimulating hormone: a retrospective analysis
  • Nadja O’Nions (GB)
    Virulence and Genomic Instability of Candida Isolates in Reproductive Tract-associated Infertility
  • Mariam Makharadze (GE)
    Effect of PGT-A on IVF Outcomes in Women Under 35: A Retrospective Comparative Study
  • Bernardo Moura (BR)
    Autologous Platelet-Rich Plasma (PRP) Intrauterine Application during the Assisted Reproduction Technique
  • Letícia Whitaker (BR)
    Breaking the Silence: Shedding Light on The Silent Consequences of Embryo Quality and Aneuploidy and Obesity in Human Development
  • Fernando Ferreira (BR)
    Can the Dual Trigger Protocol Impact Embryo Ploidy?
  • Naama Srebnik (IL)
    Dual versus single trigger in women with low ovarian reserve (LOR) undergoing Fertility Preservation: Similar Mature oocyte yield.
  • Haleema Sadia (PK)
    Data-Guided Embryo Selection for Reducing Genetic Disorders in Consanguineous IVF Cases: A South Asian Perspective
  • Gulshanoy Rakhimjonova (UZ)
    Stem Cells in Gynecology: Prospects and Innovative Therapeutic Approaches
  • Ioana Hristov (RO)
    Hyperthyroidism management in pregnancy by assisted conception- when and how to treat?
ISGE 9 Oral Presentation 15:40-17:10
ADD FAVOURITE

Adolescents

chairpersons: Nakamura Renan Massao , Giuseppe Bifulco
  • Siyu Zhou (NL)
    Association between Sleep Quality in Adolescence and Dysmenorrhea Severity in Young Adulthood: A Prospective Cohort Study
  • Elvira Nocita (IT)
    Pelvic ultrasound findings in Adolescents: a comprehensive photographic overview of 3 years
  • David Tevdorashvili (GE)
    Neurosteroid and Kisspeptin Crosstalk: A Dynamic Interface Linking Stress, Ovulation, and Reproductive Homeostasis
  • Alla Vash-Margita (US)
    Linked to Lichen: A Longitudinal Cohort Study of Patients with Premenarchal Lichen Sclerosus and Their Comorbid Conditions
  • Renan Massao Nakamura (BR)
    Burden of Abnormal Uterine Bleeding in Adolescents in a Developing Country: A Public Health and Quality of Life Crisis
  • Yang Yilin (CN)
    Secular Trend in Menarche and Determinants of Reproductive Lifespan in Chinese Women: A Nationwide Analysis
  • Nina Davidova (GE)
    Bardet-Biedl Syndrome Presenting with Abnormal Uterine Bleeding: A Case Report
  • Karina Matusiak (PL)
    Undescended ovary - is it a normal gonad?
  • Emanuela Angelini (IT)
    Polycystic ovarian morphology (PCOM) as a modifier of functional hypothalamic amenorrhea (FHA): quantitative synthesis of endocrine and metabolic outcomes
  • Oksana Makarchuk (UA)
    Secondary Amenorrhea in Young Women as a Variant of Stress-Induced Ovarian Dysfunction
  • Chrisandra Shufelt (US)
    REgistry of Very early Estrogen Loss and AnovuLation (REVEAL): An International Registry for Women with Functional Hypothalamic Amenorrhea
  • Siyu Zhou (NL)
    Association between maternal characteristics, offspring growth and pubertal timing: results from a longitudinal birth cohort study
ISGE 10 Oral Presentation 15:40-17:10
ADD FAVOURITE

Endometriosis

chairpersons: Valentino Remorgida , Anne Muendane
  • Mandy Mangler (DE)
    EDELWEISS 6: A long-term extension study to assess the effect of Linzagolix in women with endometriosis-associated pain.
  • Federica Iacobini (IT)
    When an inflammatory bowel disease (IBD) should be suspected in patients with endometriosis?
  • Anne Muendane (CH)
    Therapeutic effect and tolerance of drospirenone in women with endometriosis- a retrospective cohort study
  • Kseniia Kondrashkina (RU)
    Endometriosis as a Microbiome–Immune Interface Disorder: New Insights Into Pathogenesis and Non-Invasive Diagnostics
  • Mariami Kaviladze (RU)
    Profile of Nicotinic Acetylcholine Receptor Subunit Expression in Patients with Ovarian Endometriosis: a prospective longitudinal multicentre study
  • Ayushi Negi (IN)
    Cabergoline improves conception in endometriosis associated infertility: Case series
  • Maja Pusic Novak (SI)
    Phenotypic and Functional Characterization of Primary Endometriotic Stromal Cells for In Vitro Model Development
  • Edi Muhaxhiri (SI)
    Proteomic profile of uterine cavity lavage in endometriosis patients
  • Marcella Cedotti (BR)
    Endometriosis and Physical Exercise: Is There Improvement in Quality of Life? A Systematic Review
  • Svetlana Dubrovina (RU)
    Metabolic and Neurotransmitter Signatures of Depression Associated with Endometriosis: A Path Toward Phenotype-Oriented Therapeutic Strategies
  • Alina-Mihaela Busan-Pirvoiu (RO)
    Silent Pelvis, Loud Chest: A Rare Case of Thoracic Endometriosis Presenting with Recurrent Pneumothorax in a Previously Asymptomatic Patient
  • Marcelo Montenegro (BR)
    Exploring the Interplay Between Endometriosis and Altered Expression of Endometrial Markers: Implications for Relationships
ISGE 1 Key Lecture 17:15-17:45
ADD FAVOURITE

The science of implantation

chairperson: Donatella Caserta
  • Carlos Simon (ES)
    The science of implantation
ISGE 2 Key Lecture 17:15-17:45
ADD FAVOURITE

Sex steroids, metabolism and diabetes

chairperson: Andrea Isidori
  • Franck Mauvais-Jarvis (US)
    Sex steroids, metabolism and diabetes
ISGE 3 Key Lecture 17:15-17:45
ADD FAVOURITE

Long term treatment of VVA: key-learnings of PatiEnts satisfactiON studY (PEONY)

chairperson: Anne Gompel
  • Rossella Nappi (IT)
    Long term treatment of VVA: key-learnings of PatiEnts satisfactiON studY (PEONY)
ISGE 4 Key Lecture 17:15-17:45
ADD FAVOURITE

Emergency contraception

chairperson: Giovanni Grandi
  • Kristina Gemzell-Danielsson (SE)
    Emergency contraception
ISGE 3 Assembly 18:00-19:30
ADD FAVOURITE

ISGE General Assembly

Friday 06 March

ISGE 1 Therapeutic Forum 08:45-09:45
ADD FAVOURITE

Medical strategies to manage women with POI

chairperson: Mauro Cervigni
  • Svetlana Vujovic (RS)
    Medical strategies to manage women with POI
ISGE 2 Meet the Expert 08:45-09:45
ADD FAVOURITE

Hormones and psyche

chairperson: Claudio Soares
  • Katie Marwick (GB)
    The role of the menstrual cycle on psychiatric disorders
  • Peter Schmidt (US)
    Reproductive steroids and affective disorders in women: clinical phenotypes and substrates of differential behavioral response
ISGE 3 Meet the Expert 08:45-09:45
ADD FAVOURITE

Precision menopause hormone therapy

chairperson: Petra Stute
  • Paula Briggs (GB)
    Personalizing contraception at the menopausal transition
  • Pluvio Coronado (ES)
    Modern tools to assess eligibility and response to MHT
ISGE 4 Debate 08:45-09:45
ADD FAVOURITE

Ovarian cancer screening: is it feasible?

chairperson: Roberto Angioli
  • Dirk Timmerman (BE)
    Ovarian cancer screening: is it feasible?
  • Anna Fagotti (IT)
    Ovarian cancer screening: is it feasible?
ISGE 5 Oral Presentation 08:45-09:45
ADD FAVOURITE

Ovarian and other gynecological cancers

chairpersons: Giuseppe Vizzielli , Grazielle Marques Duarte Purcino
  • Tatielly Teles de Miranda (BR)
    EGF/HER-2/AKT-independent pathway FOXO3a expression in Uterine Smooth Muscle Tumors: Molecular factors involved in these Tumors Malignancy Risk
  • Grazielle Marques Duarte Purcino (BR)
    Molecular and Clinical Features involved in the Behavior of Carcinosarcomas, Endometrial Stromal Sarcomas (HG, LG, and UUS), and Adenosarcomas
  • Grazielle Purcino (BR)
    Blocking SHH Pathway Reduces the in Vitro Malignant Behavior of Uterine Leiomyosarcoma via Pharmacological or Genetic Inhibition of SMO
  • Nika Marolt (SI)
    Medroxyprogesterone acetate and mefenamic acid as potential strategies to overcome platinum resistance in serous ovarian carcinoma
  • Marija Gjorgoska (SI)
    Clinical Differentiation of Ovarian Cancer and Non-Malignant Adnexal Masses Using Serum Steroid–Protein Signatures
  • Melis Altug Inan (TR)
    Hormonal and Hemodynamic Influences of Pregnancy on Central Nervous System Tumors: A Meningioma-Based Case Series
ISGE 6 Oral Presentation 08:45-09:45
ADD FAVOURITE

Gestational hypertension, pre-eclampsia, and eclampsia

chairpersons: Tullio Ghi , Valentyna Volianska
  • Ayushi Negi (IN)
    Sequential trends in estimated glomerular filtration rate and serum creatinine Across Trimesters in Healthy and Complicated Pregnancies
  • Ritu Kushwah (IN)
    Early Pregnancy Renal Function as a Predictor of Preeclampsia: A Prospective Study
  • Valentyna Volianska (UA)
    Analysis of Cognitive Dysfunction in Pregnant Women with Hypertension
  • Bakhodir Kurbanov (UZ)
    Features of mitochondral dysfunction in hypertension during pregnancy.
  • Jose Lucas Santana (BR)
    The Impact of Advanced Maternal Age on Hypertensive Disorders of Pregnancy Trends: A Nationwide Study of 1 > Million Hospitalizations (Brazil, 2014-2023)
ISGE 7 Oral Presentation 08:45-09:45
ADD FAVOURITE

Sexual health, dysfunctions, and transgender health

chairpersons: Jovanovic Milica , Angelica Lindén Hirschberg
  • Rosalind Foster (AU)
    Frequency of Genitourinary Syndrome of Menopause Symptoms in Chinese Speaking Sex Workers attending an Urban Sexual Health Clinic in Sydney, Australia
  • Milica Jovanovic (RS)
    Bone Mineral Density in Transgender Women during the First Year of Gender – Affirming Hormone Therapy
  • Ashleigh Woodland (GB)
    Progesterone Hypersensitivity - A Case Report and Discussion of Current Evidence.
  • Sofia Tornvall (SE)
    The androgen profile in relation to sexual function across the menstrual cycle in young, healthy women
  • Jose Luis Rojas Oviedo (CO)
    Trombosis de senos venosos asociada con el uso de testosterona como terapia hormonal de afirmación de género (THAG) en un paciente transgénero: reporte de caso y revisión de la literatura
  • Stefan Ückert (AF)
    Sexual Dysfunctions - A Burden of the Ageing/Menopausal Woman only? A Study in a Cohort of Young Females
ISGE 8 Scientific Society Symposium 08:45-09:45
ADD FAVOURITE

Ovarian Cryopreservation and retransplantation: first cryobank in China

Organized by Chinese Society of Gynecological Endocrinology (CSGE)
chairpersons: Xiangyan Ruan , Alfred Mueck
  • Muqing Gu (CN)
    Advances in preservation of ovarian function and fertility in children and young women
  • Zecheng Wang (CN)
    POI database of China – worldwide largest datebase
  • Mingzhen Zhang (CN)
    Prepubertal Ovarian Tissue Cryopreservation and Adolescent Transplantation: Case Report
  • Matthias Korell (DE)
    Indications for ovarian cryopreservation and retransplantation: Comparing China with Europe
ISGE 9 Scientific Society Symposium 08:45-09:45
ADD FAVOURITE

Latest news from the menopause world

Organized by International Menopause Society
  • Tommaso Simocini (IT)
    Changing menopause landscape – key information and reasoning
  • Rossella Nappi (IT)
    Highlights from the last IMS recommendations
  • Peter Chedraui (EC)
    Physical exercise and other lifestyle principles in menopause care
  • Santiago Palacios (ES)
    GSM: latest recommendations from the 5th International Consultation on Sexual Medicine
ISGE 10 Scientific Society Symposium 08:45-09:45
ADD FAVOURITE

Progestins and Meningioma Risk: Bridging Epidemiological Evidence and Clinical Practice

Organized by Swiss Society of Gynecologic Endocrinology, Contraception and Menopause (SGEM)
chairpersons: Ursula Gobrecht-Keller , Susanna Weidlinger
  • Lea Hoisnard (FR)
    Understanding the Evidence
  • Gabriele Merki (CH)
    Implications for Clinical Practice
ISGE 1 Symposium 09:50-11:20
ADD FAVOURITE

The troubled journey of the menopausal transition

chairpersons: Antonio Cano , Mark Brincat
  • Panagiotis Anagnostis (GR)
    Is early menopause a different entity than POI?
  • Roberta Brinton (US)
    The stages of the menopausal transition and its implications for hormone therapy intervention
  • Tommaso Simoncini (IT)
    Understanding the clinical journey of the menopausal transition
  • Stavroula Paschou (GR)
    Obesity across menopause
ISGE 2 Panel Discussion 09:50-11:20
ADD FAVOURITE

Understanding the value of natural estrogens: from global consensus to clinical application with E4/DRSP

Sponsored by Gedeon Richter
chairpersons: Matts Olovsson , Andrea Genazzani
  • Kristina Gemzell-Danielsson (SE)
    Panelist
  • Jean-Michel Foidart (BE)
    Panelist
  • Jonathan Douxfils (BE)
    Panelist
ISGE 3 Symposium 09:50-11:20
ADD FAVOURITE

Endocrine disorders and woman’s health

chairpersons: Peter Chedraui , Davide Lauro
  • Elene Asanidze (GE)
    Complete Androgen Insensitivity Syndrome: Complexities in Diagnosis, Management, and Long-Term Follow-Up
  • Eleni Armeni (GB)
    The thyroid gland and woman’s health
  • Andrzej Milewicz (PL)
    How vitamine D deficiency influence on obesity and diabetes mellitus type 2
  • Ricardo Azziz (US)
    PCOS, Metabolism, and Obesity
ISGE 4 Symposium 09:50-11:20
ADD FAVOURITE

Modern contraception

chairpersons: David Vasquez Awad , Andrea Ciavattini
  • Cuauhtemoc Celis (MX)
    Combined hormonal contraception for abnormal uterine bleeding
  • Manuela Farris (IT)
    Overcoming barriers to hormonal contraception
  • Nilson De Melo (BR)
    Modern contraception in Latin America
  • Ineta Vasaraudze (LV)
    Obesity & Contraception: Opportunities, Challenges and Threats in the Modern World
ISGE 5 CORSO ECM 09:50-13:20
ADD FAVOURITE

Approccio clinico integrato alla salute ginecologica della donna: dalla transizione menopausale alle principali patologie benigne uterine

Organized by AIGE
chairpersons: Christian Battipaglia , Stefano Luisi
  • Alessandro Genazzani (IT)
    La scelta di terapia: dalla transizione, verso la menopausa e oltre!
  • Eleonora Russo (IT)
    Il distretto genito-urinario: dall’inquadramento alla gestione terapeutica con la transizione menopausale
  • Christian Battipaglia (IT)
    Il metabolismo osseo: ciò che il ginecologo deve valutare per poi fare
  • Andrea Giannini (IT)
    AUB come sintomo: causa organica o disendocrina?
  • Massimo Stomati (IT)
    I vantaggi della innovazione nel trattamento della fibromatosi e dell’endometriosi
  • Antonio La Marca (IT)
    La ricerca di gravidanza nella paziente con endometriosi o fibromatosi
ISGE 6 Oral Presentation 09:50-11:20
ADD FAVOURITE

Gestational diabetes mellitus

chairpersons: Fabio Facchinetti  , Lina Bahniy
  • Prodipta Chowdhury (BD)
    Intestinal Alkaline Phosphatase: A Novel Enteric Biomarker in Gestational Diabetes Mellitus
  • Elīna Priede (LV)
    Assessment of Care Quality and Follow-Up Gaps in Latvian Patients with Gestational Diabetes Mellitus (LATGDM): Two-Year Data
  • Michaela Svojtkova (CZ)
    Endocrine disruptors, steroid hormones and its role in gestational diabetes mellitus
  • Marina Martinelli Sonnenfeld (BR)
    Gestational Weight Gain versus Pre-pregnancy Obesity: Distinct Paths, Similar Risks for Mothers and Newborns
  • Emilio Diaz (CL)
    Extracellular Vesicles from Gestational Diabetes Mellitus Pregnancies Alter Hepatic Inflammation and Metabolism: Clinical and Functional Correlations
  • Lina Bahniy (UA)
    The influence of coagulation homeostasis disorders on the development of obstetric complications in pregnant women with metabolic-associated steatohepatitis and obesity
  • Muhammad Pradhiki Mahindra (GB)
    Preliminary Microfluidic Ektacytometry Investigation Using Postnatal Umbilical Cord Blood Hemorheology in Pregnancy with Glucose Dysmetabolism
  • Muhammad Pradhiki Mahindra (GB)
    A Prospective Cohort Study of Insulin Physiology, Disposition Index, and Pregnancy Outcomes of Glucose Tolerance Test Values Heterogeneity during Pregnancy: PROTEKT Study
ISGE 7 Oral Presentation 09:50-11:20
ADD FAVOURITE

Adolescents 2

chairpersons: Charles Sultan , Bakhodir Kurbanov
  • Nuria Pretel Garrido (ES)
    FSH RECEPTOR GENE MUTATION IN A PATIENT WITH AMENORRHEA
  • Florin Isopescu (RO)
    The Impact of nutritional habits in the onset age of menarche in a Romanian County
  • Luana Cunha Machado (BR)
    Knowledge about Contraceptive Methods among Adolescents and Adult Women
  • Corina Darii (MD)
    Long-Term Outcomes Following Early Combined Oral Contraceptive Use among Moldovan Women
  • Renan Massao Nakamura (BR)
    Abnormal Uterine Bleeding (AUB) as a Determining Factor for Reduced Quality of Life in Adolescents in a Middle-Income Country Context
  • Hidayat Mammadzada, MD (AZ)
    46, XX male syndrome : A Case Report
  • Olarik Musigavong (TH)
    “Breaking the Silence: Digital Engagement Strategies for Adolescent Contraception”
  • Angelica Lindén Hirschberg (SE)
    Multicenter trial evaluating the safety and tolerability of estetrol-drospirenone combined oral contraceptive in postmenarchal female adolescents
  • Bakhodir Kurbanov (UZ)
    Neuroendocrine Correlates of Reproductive Health in Girls with Autism Spectrum Disorder
ISGE 8 Scientific Society Symposium 09:50-11:20
ADD FAVOURITE

Treatment of menstrual disorders

Organized by Società italiana di Ginecologia e Ostetricia (SIGO)
chairpersons: Felice Petraglia , Elsa Viora
  • Rossella Nappi (IT)
    Premenstrual syndrome
  • Stefano Angioni (IT)
    Dymenorrhea
  • Antonio Maiorana (IT)
    Heavy menstrual bleeding
  • Stefano Luisi (IT)
    Amenorrhea
ISGE 9 Scientific Society Symposium 09:50-11:20
ADD FAVOURITE

Hormone-free management of menopause: Controversial options for the management of GUSM and VMS

Organized by European Society of Gynecology
chairpersons: Błażej Męczekalski , Tevfik Yoldemir
  • Andrea Giannini (IT)
    Laser in the management of GUSM and other pelvic conditions: YES
  • Camil Castelo-Branco (ES)
    Laser in the management of GUSM and other pelvic condition: NO
  • Mark Brincat (MT)
    Complementary & alternative medicine for management of vasomotor symptoms: YES
  • Ludwig Kiesel (DE)
    Complementary & alternative medicine for management of vasomotor symptoms: NO
ISGE 10 Scientific Society Symposium 09:50-11:20
ADD FAVOURITE

Navigating the Contours of Controversy in Polycystic Ovary Syndrome (PCOS)

Organized by SOBRAGE
chairperson: Sebastião De Medeiros
  • Edmund C Baracat (BR)
    Incomplete Phenotypes: Are They Truly PCOS?
  • Ana Carolina J S Rosa e Silva (BR)
    Metabolic Disturbances: What Matters Most?
  • Gustavo A. R. Maciel (BR)
    New PCOS Treatments: What to Do Next?
  • Jose Maria Soares Jr (BR)
    Probiotics and PCOS: Hype or Hope?
ISGE 2 Symposium 11:50-13:20
ADD FAVOURITE

Sleep and menopause – unravelling the complexity

Sponsored by Bayer
chairpersons: Rossella Nappi , Giovanni Grandi
  • Rossella Nappi (IT)
    Welcome and introduction
  • Zoe Schaedel (GB)
    Talking about sleep – can real world data help us start the conversation?
  • Fiona Baker (US)
    Not all sleep disturbances are the same
  • Claudio Soares (CA)
    Managing sleep disturbance in menopause
  • Rossella Nappi (IT)
    Summary and close
ISGE 3 Symposium 11:50-13:20
ADD FAVOURITE

Purified and specific pollen extracts: peri and menopause management, clinical data, mechanism of action

Sponsored by Sérélys by UPSA
chairpersons: Andrea Genazzani , Frederick Naftolin
  • Tommaso Simoncini (IT)
    Providing a broader overview of perimenopause and menopause
  • Santiago Palacios (ES)
    Discussing clinical outcomes with purified and specific pollen extracts
  • Peter Chedraui (EC)
    Presenting the experimental data on the mode of action of PureCyTonin
ISGE 4 Symposium 11:50-13:20
ADD FAVOURITE

A modern view of PCOS

chairpersons: Ricardo Azziz , Giuseppe Gullo
  • Alessandro Genazzani (IT)
    The neuroendocrine loop of PCOS
  • Francis de Zegher (BE)
    Early development of adolescent PCOS
  • Lourdes Ibáñez (ES)
    Diagnosis and future treatments of adolescent PCOS
  • Petra Stute (CH)
    Features and challenges in the management of PCOS in migrants
ISGE 6 Symposium 11:50-13:20
ADD FAVOURITE

The endometrium

chairpersons: Ettore Cicinelli , Camil Castelo-Branco
  • Caterina Exacoustos (IT)
    Modern endometrial imaging
  • Angelica Linden Hirschberg (SE)
    The latest about breast and endometrial safety for bioidentical progesterone in MHT
  • Francesco Fanfani (IT)
    Modern management of endometrial cancer
  • Andrea Giannini (IT)
    Hormonal and metabolic control of endometrial hyperplasia and cancer
ISGE 7 Scientific Society Symposium 11:50-13:20
ADD FAVOURITE

Infertility 35+

Organized by GGRC - Georgian-German Reproductive Center
chairpersons: Archil Khomasuridze , Nino Muserize
  • Nino Muserize (GE)
    Inflammation State of Endometrium in Women of Reproductive Age
  • Maurizio Guida (IT)
    Focus on Uterine Fibroids, their Classification and New Treatment Strategies
  • Viacheslav Lokshin (KZ)
    Infertility After 40: A Challenge for Modern Reproductive Medicine
  • Madona Jugeli (GE)
    Managing Cervical Pathology Prior to ART: The Role of Coordinated Care Between Gynecologists and Reproductive Specialists
  • Nato  Shamugia (GE)
    Managing Cervical Pathology Prior to ART: The Role of Coordinated Care Between Gynecologists and Reproductive Specialists
  • Oliko Murgulia (GE)
    Phenotypic features of chronic endometritis, persistence and progression molecular markers.
  • Nino Davidova (GE)
    The Role of Progesterone Induced Blocking Factor in Early Pregnancy Loss
  • Lali Melia (GE)
    Art-Conceived Pregnancies: Mechanisms and Predictors of Hypertensive Complications
  • Nia Metonidze (GE)
    Gestational Diabetes Mellitus Risk Factors and Thyroid Dysfunction
  • Nani Tatishvili (GE)
    Adenomyosis and art: navigating the path to parenthood
ISGE 8 Scientific Society Symposium 11:50-13:20
ADD FAVOURITE

Analysis of Potential Transgenerational Impacts of Contemporary War on Various Aspects of Health: lessons from Ukraine

Organized by Ukrainian Society of Gynecologists Endocrinologists (USGE)
chairperson: Tetiana Tatarchuk
  • Natalia Pedachenko (UA)
    What we Knew and what we Learnt about the Interactions of Prolonged Stress and Neuroendocrine Regulation of Reproduction
  • Oleksandra Gromova (UA)
    The psychological Profile of Women in a Gynecological Setting
  • Liudmyla Kalugina (UA)
    Reproductive Aging and menopausal transition: The Role of Social and Environmental Factors in the 21st Century
  • Taisiia Krysenko (UA)
    A Dual Challenge in PCOS: Which Matters More, Anxiety or Depression? Exploring the impact of chronic war-related stress and current social challenges
  • Kateryna Plaksiieva (UA)
    Environmental Exposures of War and Women’s Health: International Evidence and Implications for Ukraine
ISGE 9 Scientific Society Symposium 11:50-13:20
ADD FAVOURITE

Frequent Questions in the Care of Women During Menopause: A Practical Approach

Organized by Associação Brasileira de Climatério (SOBRAC)
chairperson: Cesar Eduardo Fernandes
  • Nilson Roberto De Melo (BR)
    Until when should contraceptive methods be maintained during the menopausal transition?
  • Luciano De Melo Pompei (BR)
    What is the risk of breast cancer associated with menopausal hormone therapy?
  • Rogério Bonassi Machado (BR)
    Can the levonorgestrel intrauterine system be used for endometrial protection?
ISGE 10 Scientific Society Symposium 11:50-13:20
ADD FAVOURITE

Modern Gynecological Endocrinology

Organized by Polish Society of Gynecological Endocrinology (PTEG)
chairpersons: Błażej Męczekalski , Andrzej Milewicz
  • Anna Szeliga (PL)
    Metabolic disorders in PCOS patients - where do we stand?
  • Katarzyna Suchta (PL)
    Personality traits and psychological profiles in women with Polycystic Ovary Syndrome - an undervalued issue in clinical practice
  • Maciej Wilczak (PL)
    HYSTERO-BLOCK SYSTEM Gubbini Mini Hystero-Resectoscopy diagnostic and operative hysteroscopy in local anesthesia. Polish experiences
  • Grzegorz Jakiel (PL)
    MHT in women at increased oncological risk
ISGE 1 Lunch Symposium 13:40-15:10
ADD FAVOURITE

Menopause beyond symptoms: individualized pathways and holistic multisystem approach

Sponsored by Theramex
chairperson: Rossella Nappi
  • Rossella Nappi (IT)
    Opening the dialogue: setting the scene for new perspectives
  • Petra Stute (CH)
    Decoding the evidence: from real-world insights to individualized practice
  • Marco Gambacciani (IT)
    Pathways of individualization: choices that matter navigating MHT options
  • John Stevenson (GB)
    Beyond symptoms: cracking the heart code - Estrogens in cardiovascular and cardiometabolic function
  • Jean Yves Reginster (CH)
    Beyond symptoms: strength beneath the surface - MHT and osteoporosis prevention
  • Rossella Nappi (IT)
    Bringing it together: key takeaways and Faculty Q&A
ISGE 2 Symposium 15:40-17:10
ADD FAVOURITE

Endometriosis and Adenomyosis

chairpersons: Katerina Exacoustos , Gabriele Merki
  • Ludwig Kiesel (DE)
    Understanding the basis of endometriosis and adenomyosis
  • Felice Petraglia (IT)
    The evolution of medical treatments for endometriosis and adenomyosis
  • Tevfik Yoldemir (TR)
    Endometriosis in Perimenopause and postmenopause
  • Stefano Angioni (IT)
    Fertility-sparing endometriosis surgery
ISGE 3 Panel Discussion 15:40-17:10
ADD FAVOURITE

Championing women’s voices in menopause: broadening the clinical lens - Menopause case study discussion: symptoms, risks, and best practice clinical care

Organized by The Women's Health Academy (WHA)
chairperson: Andrea Genazzani
  • Rossella Nappi (IT)
    Welcome and introduction
  • Michelle Jacobson (CA)
    Panelist
  • Rossella Nappi (IT)
    Panelist
  • Claudio Soares (CA)
    Panelist
  • Rossella Nappi (IT)
    Summary and close
ISGE 4 Symposium 15:40-17:10
ADD FAVOURITE

Health Consequences of functional hypothalamic amenorrhea

chairpersons: Carmine Nappi , Błażej Męczekalski
  • Sarah Berga (US)
    Stress weight and reproductive function
  • Chrisandra Shufelt (US)
    The silent impact of stress: health consequences of FHA
  • Rosanna Apa (IT)
    Irisin and Bone Status in FHA: there is a role for post-menopausal osteoporosis
ISGE 5 ISGE Scholarship course 15:40-18:50
ADD FAVOURITE

Course 3

  • Leyla Adamyan (RU)
    The role of surgery in endometriosis
  • Nicola Pluchino (CH)
    Preserving and fostering fertility in endometriosis
  • Nestor Siseles (AR)
    The evolution of menopause hormone therapy
ISGE 6 Symposium 15:40-17:10
ADD FAVOURITE

Modern concepts in ovarian cancer

chairpersons: Francesco Fanfani , Alfredo Ercoli
  • Marta Caretto (IT)
    Contraception and MHT in women with BRCA 1/2 mutations
  • Dirk Timmerman (BE)
    State-of-the-Art Diagnostic Approaches in Ovarian Cancer
  • Roberto Tozzi (IT)
    The evolution of mini-invasive surgery for ovarian cancer
  • Jenifer Sassarini (GB)
    Managing menopause after gynecological cancer
ISGE 7 Oral Presentation 15:40-17:10
ADD FAVOURITE

Climacteric syndrome and menopause

chairpersons: Angelica Monterrosa-Blanco , Irene Lambrinoudaki
  • Ayse Nur Cakir Gungor (TR)
    EFFECT of MENOPAUSAL HORMONE REPLACEMENT THERAPY on OXIDATIVE/ANTIOXIDATIVE PATHWAYS
  • Angelica Monterrosa-Blanco (CO)
    Brain fog in menopause, a new symptom and its relationship with traditional menopausal manifestations
  • Stephanie Faubion (US)
    Impact of BMI on Perimenopause Symptom Burden: Insights from the Flo App
  • Uglješa Barać (RS)
    Multilingual, Peer-Reviewed Menopause Education Through CoMICs: Sustained Global Engagement and Improved Accessibility via the MEET Initiative
  • Jenny Lee (NL)
    Temporal Sleep–Mood–Cognition Dynamics in Perimenopause Using Patient Generated Health Data (PGHD) and Wearables: ASTRED2 Study Design
  • Carina Dinkel-Keuthage (DE)
    Persistent Burden of Sleep Disturbances and Vasomotor Symptoms in Women Experiencing Menopause: Associations with Health-Related Quality of Life
  • Marianne Natvik (NO)
    “Is it menopause? Is it… I don’t know.” A reflexive thematic analysis of interviews with menopausal women
  • Sigal Shaklai (IL)
    Validation of the Hebrew Version of the Menopause Rating Scale (MRS): A Cross-Sectional Study
  • Tina Ellinor Rosland (NO)
    All-cause mortality after hysterectomy and bilateral oophorectomy in HUNT, validated using surgical records: a prospective cohort study.
  • Fiona Baker (US)
    ESTeeM: Burden of Menopause-Related Sleep Disturbances, Quality of Life and Work Productivity in Women in a Real-World Setting
ISGE 8 Oral Presentation 15:40-17:10
ADD FAVOURITE

PCOS 3

chairpersons: Sofia Tornvall , Fulvio Zullo
  • Enrique Reyes-Muñoz (MX)
    Metabolic characteristics of different phenotypes in Mexican women with polycystic ovary syndrome and infertility
  • Beatrice Paola Fodaro (IT)
    The role of anti-Müllerian hormone in the polycystic ovary syndrome:clinical and hormonal implications.
  • George Tevdorashvili (GE)
    Bridging Opposite Ends of Reproductive Neuroendocrinology: GABA in PCOS and FHA
  • Mariya Khmil (UA)
    Preconception Nutraceutical Intervention Optimizes Ovulation Induction Outcomes in Women with Polycystic Ovary Syndrome
  • Vyjayanthi Srinivasan (IN)
    Novel Letrozole Therapy for PCOS women with High AMH : Intracycle Extended regimen/Dose-Escalated Approach
  • Ana Julia Fonseca Carneiro Monteiro (BR)
    The Impact of Aging on Polycystic Ovary Syndrome: Longitudinal Changes in Hormonal and Cardiometabolic Profiles
  • Shobhana Patted (IN)
    Feasibility of the evidence-based “PCOS GP Tool” for diagnostic evaluation of polycystic ovary syndrome among infertile women with irregular cycles: a prospective clinical study from India
  • Neena Malhotra (IN)
    Redefining ovarian response in PCOS: Does oocyte maturity and quality matter in predicting IVF outcomes
  • Darija Mateja Strah (SI)
    Clinical characteristics and treatment preferences of women with PCOS in a private gynecological diagnostic institution in Slovenia.
ISGE 9 Scientific Society Symposium 15:40-17:10
ADD FAVOURITE

Psychosocial factors in fertility and reproduction

Organized by Associazione Ginecologi Universitari Italiani (AGUI)
chairperson: Luigi Nappi
  • Alessandra Andrisani (IT)
    Psychosocial implications of ART
  • Antonella Cromi (IT)
    Emerging psychosocial aspects in pregnancy
  • Tommaso Simoncini (IT)
    Genital mutilations
  • Tullio Ghi (IT)
    Deliveries in women with genital mutilations
  • Francesco Fanfani (IT)
    Discussion
  • Paolo Mannella (IT)
    Discussion
ISGE 10 Scientific Society Symposium 15:40-17:10
ADD FAVOURITE

Male contraception; an unmet need

Organized by International consortium for male contraception
chairpersons: Maria Cristina Meriggiola , Regine Sitruk-Ware
  • John Reynolds (UK)
    Hormonal methods in the pipeline
  • Regine Sitruk-Ware (US)
    Final results phase 2b NES/T gel
  • Stephanie Page (US)
    New non-hormonal contraceptive products
ISGE 2 Key Lecture 17:15-17:45
ADD FAVOURITE

Re- focus approach to gastronomy, endocrinopathy and women's health

chairperson: Marco Palumbo
  • Anne Beatrice Kihara (KE)
    Re- focus approach to gastronomy, endocrinopathy and women's health
ISGE 3 Key Lecture 17:15-17:45
ADD FAVOURITE

Menopause and the heart

chairperson: John Stevenson
  • Angela Maas (NL)
    Menopause and the heart
ISGE 4 Key Lecture 17:15-17:45
ADD FAVOURITE

The evolution of gynecologic oncology

chairperson: Christel Pequeux
  • Pier Luigi Benedetti Panici (IT)
    The evolution of gynecologic oncology
ISGE 6 Key Lecture 17:15-17:45
ADD FAVOURITE

Premature Ovarian Failure: Emerging Therapeutic Strategies

chairperson: Svetlana Vujovic
  • Joseph Schenker (IL)
    Premature Ovarian Failure: Emerging Therapeutic Strategies
ISGE 7 Scientific Society Symposium 17:15-18:50
ADD FAVOURITE

Insulin Resistance and Risk for Diabetes in PCOS – from Bench to Bedside

Organized by PCOSSI - The PCOS Society of India
chairpersons: Patil Madhuri , Patted Shobha , Jirge Padmarekha , Mahajan Nalini
  • Duru Shah (IN)
    Metabolic Imprints: Insulin Resistance from the womb to puberty
  • Vyjayanthi Srinivasan (IN)
    Insulin Resistance: the hidden barrier to Fertility in PCOS
  • Charmila Ayyavoo (IN)
    Pregnancy & Insulin: Balancing Metabolic Demands
  • Chandrika Anand (IN)
    The Brain- Body Connection: Insulin Resistance and Mental Health
  • Kanthi Bansal (IN)
    Metabolic Transition in Menopause: the Role of Insulin Resistance
ISGE 8 Oral Presentation 17:15-18:45
ADD FAVOURITE

Menopause and hormonal therapy

chairpersons: Pablo Carpintero , Nilufar Bakoeva
  • Zhenrun Zhan (CN)
    Glycolipotoxicity regulates the mechanism of ACSL4/ALOX15- induced osteoclast iron death to osteoporosis through AGPAT3
  • Helen Ryan (IE)
    Impact of a Single Multidisciplinary Menopause After Cancer Clinic Visit on Symptom Burden and Quality of Life: A Prospective Cohort Study
  • Giovanni Grandi (IT)
    Improvement of vasomotor symptoms of perimenopausal women with symptomatic fibroids treated with relugolix 40 mg combination therapy
  • Antonina Smetnik (RU)
    Characteristics of MHT use among peri- and postmenopausal women: results of a large survey
  • Paul Piette (BE)
    Optimization of transdermal estradiol gel and micronised progesterone for menopausal hormone therapy
  • Peter Greenhouse (FR)
    Suicidal ideation in perimenopausal PMDD: Qualitative review & response to transdermal estradiol
  • Jean-Michel Foidart (BE)
    General safety profile of estetrol (E4) after 12 weeks of treatment in postmenopausal women: results from the phase 3 E4COMFORT I study
  • Jonathan Douxfils (BE)
    Effect of Estetrol on Acquired Activated Protein C Resistance in Postmenopausal Women: A Phase 3 Randomized Trial
  • Santiago Palacios (ES)
    Estetrol (E4) Provides Complete Relief from Vasomotor Symptoms in One-Third of Participants in the E4COMFORT I Phase 3 Clinical Trial
  • Carolina Furtado Macruz (BR)
    To evaluate the clinical parameters and bone profile of postmenopausal women from 2022 to 2024 in a menopause outpatient clinic in São Paulo
  • Nancy Yaneth Contreras Garza (MX)
    Cardiovascular outcomes of menopause hormone therapy initiated in women aged ≥60 years or ≥10 years post-menopause: A systematic review of the literature
ISGE 9 Oral Presentation 17:15-18:45
ADD FAVOURITE

Fertility and Gynecological Endocrinology - Late Abstract

chairpersons: Chrisandra Shufelt , Marta Caretto
  • Rosella Nappi (IT)
    Achieving Equity in Contraceptive Care: Global Access and Policy Implications for Natural Estrogens
  • Antonella Guarino (IT)
    Is it possible to hypothesize an epigenetic role of folates in the endocrine–metabolic axis of young women with acrosyndromes and menstrual disorders?
  • Ying Xiong (CN)
    Pulsatile GnRH therapy in Fertility Restoration of Hypothalamic Amenorrhea
  • Margarit Grigoryan (AM)
    Our Experience Using Dydrogesterone in Two Novel Reproductive Protocols: Progestin-Primed Ovarian Stimulation with GnRH Agonist Trigger and Programmed-Ovulatory Frozen Embryo Transfer without hCG
  • Melis Altug Inan (TR)
    Reproductive Endocrine Stability Despite Persistent Hypogonadism in Well-Chelated Adult Women with Transfusion-Dependent β-Thalassemia
  • Dominika Gałczyńska (PL)
    Secundary amenorrhea and ectopic adrenal tissue in the Douglas’ pouch: a case report
  • Nargiz Shamsadinskaya (AZ)
    Hidden Burden of Infertility: Sexual Dysfunction and Anxiety in Women Assessed by FSFI and Zung Scales
  • Enkeleda Prifti (AL)
    Efficacy and safety of using semaglutide in obese women with PCOS
  • Vusala Taghiyeva (AZ)
    Association Between Sexual Behavior and High-Risk HPV Genotypes in Women with HPV-Related Pathology
  • Vusala Taghiyeva (AZ)
    A di̇fferenti̇ated approach to the management of patients with cervical intraepithelial lesions associated with high-risk human papillomavirus (hr-hpv) types
ISGE 10 Oral Presentation 17:15-18:45
ADD FAVOURITE

Gynecological and Obstetrical Endocrinology - Late Abstract

chairpersons: Eleni Armeni , Elene Asanidze
  • Ada Gjuzi (AL)
    Myometrial Vascular Enlargement Versus Uterine Arteriovenous Malformations: A Diagnostic Clinical Challenge
  • Jose Maria Soares-Jr (BR)
    Melatonin Supplementation in Ovarian Response: A Double-Blind Randomized Controlled Trial on Follicular Fluid Melatonin Levels and Reproductive Outcomes in Infertile Women
  • Leslie Mariana Patiño Adán (MX)
    Case Report. Glucagon-Like Peptide-1 Receptor Agonist therapy for obesity in women with ovulation induction: follicular and endometrial findings
  • Vladislava Khalenko (RU)
    Modulating Maternal Immunity: The Role of Paternal Lymphocyte Immunization
  • Venera Malaniya (UA)
    Personalized Ovulation Induction in PCOS: A Response-Based Strategy Using Letrozole Alone and Letrozole Plus Early Low-Dose Gonadotropins
  • Vladislava Khalenko (RU)
    Cervical Remodeling Phenotypes Identified by Ultrasound Elastography and Biomarkers and Their Association with Preterm Birth
  • Carmen Padilla Prieto (ES)
    Electrohysterography and inflammatory biomarkers to predict delivery ≤7 days after PPROM: preliminary results of a pilot study
  • Carmen Padilla Prieto (ES)
    Electrohysterography in Twin Pregnancies: Evidence of Uterine Overdistension and Early Myometrial Activation
  • Olga Pustotina (RU)
    Intrauterine non-ablative erbium laser for endometrium restoration in infertile women with implantation failures
  • Xinmei Zhang (CN)
    The clinical efficacy of dydrogesterone in the treatment of endometriosis: A follow-up study
ISGE 2 Meet the Expert 17:45-18:45
ADD FAVOURITE

The challenges of premature ovarian insufficiency

chairperson: Archil Khomasuridze
  • Svetlana Vujovic (RS)
    Role of adrenal and ovarian androgen steroid levels in premature ovarian insufficiency
  • Kenny Rodriguez Wallberg (SE)
    Fertility Preservation for patients with Turner syndrome and high risk of POI
ISGE 3 Meet the Expert 17:45-18:45
ADD FAVOURITE

From GSM to pelvic floor dysfunction

chairperson: Chiara Benedetto
  • Eleonora Russo (IT)
    Understanding bladder function through menopause and ageing
  • Tim Hillard (GB)
    Menopause and urinary incontinence, the way to go
ISGE 4 Oral Presentation 17:45-18:45
ADD FAVOURITE

Breast cancer

chairpersons: Valentina Bounous , Manon Zielonka
  • María Quintero-Parada (CO)
    Religiosity: A Factor Related to Resilience in Postmenopausal Colombian Women Breast Cancer Survivors
  • Manon Zielonka (BE)
    Enhancing Breast Cancer Sensitivity to Endocrine Therapies Through Intermittent Estrogen Exposure : A Proof Of Concept
  • Claus M. Schlotter MD (DE)
    High proliferation, amplified c-myc, and unfavorable Tumor Microenvironment (TME) composition are linked to endocrine therapy resistance in early hormone-positive/HER2-negative (e HR+/HER2-) Breast Cancer (BC)
  • Camille Flas (BE)
    Impact of menopause treatments on the tumor microenvironment
  • Yuejiao Wang (CN)
    Serum miR-181a and PGRMC1 as Novel Combined Biomarkers for Improved Early Detection of Breast Cancer
  • Jose Maria Soares-Jr (BR)
    Circadian Clock Disruption in Tumor Biology: Strong PER2 Expression Is Associated with Inferior Outcomes in Breast Cancer After Neoadjuvant Chemotherapy
  • Beniamin Grabarek (PL)
    Subtype-Independent Dysregulation of Hippo Pathway Genes in Breast Cancer
ISGE 6 Oral Presentation 17:45-18:45
ADD FAVOURITE

Menopause - Late Abstract

chairpersons: Santiago Palacios , Panagiotis Anagnostis
  • Rossella E. Nappi (IT)
    Effect of fezolinetant on weight, waist circumference, BMI, and BRI: data from phase 3, randomised, double-blind, placebo-controlled studies (SKYLIGHT 1, 2, and 4) over 52 weeks
  • Nigar Kamilova (AZ)
    Endocrine determinants of genitourinary syndrome of menopause in Azerbaijani postmenopausal women: a late-breaking population-specific analysis
  • Rossella Nappi (IT)
    Safety and tolerability of elinzanetant: Pooled analysis from multiple clinical trials
  • Maria Alejandra Belardo (AR)
    Use of oxybutynin in vasomotor symptoms: a preliminary study
  • Sylvia Asaka Yamashita Hayashida (BR)
    Targeting Modifiable Risks: A Call for Action in the Management of Postmenopausal Osteoporosis Based on a Decade of Real-World Data from Brazil
  • Gianluca Simoncini (IT)
    Lipofilling with Nanofat tecnique for Refractory Vulvar Disease: Prospective Evidence in Lichen Sclerosus and Vaginal Atrophy
ISGE 3 Closing Ceremony 18:50-19:10
ADD FAVOURITE

Closing Ceremony